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ABSTRACT 
 
Microcystin (MC-LR) is a potent toxin and its presence in drinking water create a 
serious risk to human health. This paper presents the degradation of MC-LR in water by 
iron-based molecules, ferrates (FeVIO4
2-, FeVO4
3-, and FeIVO4
4-) at pH 7.0. The oxidized 
products (OPs) were analyzed at various concentrations of ferrate species. Product 
studies showed the fragmentation of the cyclic MC-LR by all ferrates, which varied with 
the concentration and the oxidation state of ferrates. Three predominant degradation 
pathways are proposed, involving hydroxylation and breakage of peptide bond of MC-
LR. The extent of hydroxylation of MC-LR by FeVI was more than by FeV and FeIV. FeVI 
oxidation has potential to generate OPs with low molecular weight. Additionally, three 
pH (4.0, 7.0 and 9.0) were investigated to learn their on three pathways of MC-LR by 
FeVI, FeV, and FeIV. Analysis of peak areas of OPs showed that acidic conditions greatly 
facilitated the hydroxylation by three ferrates compared with the neutral and basic pH. 
Antibiotics have recently attracted increasing concern worldwide due to their 
ubiquitous occurrence and negative ecological effects on aquatic organisms. This paper 
investigated the oxidation kinetics and mechanisms of sulfadiazine (SDZ), a 
representative sulfonamide, by FeVI. The results showed that the reaction followed the 
second-order kinetics, and the rate constants decreased with the increasing pH from 4.0 
to 10.0. Eleven OPs of SDZ were identified, and three initial pathways were proposed, 
including SO2 extrusion, deamination, and hydroxylation, of which the involvement of 
SO2 extrusion was first demonstrated during Fe
VI oxidation of SDZ. 
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In addition, the removal of flumequine (FLU), a representative fluoroquinolone 
antibiotic, by FeVI, FeV, and FeIV species and the effect of ammonia were studied. The 
results indicated that FeVI exhibited a higher capability for the elimination of FLU than 
FeV and FeIV. Furthermore, the presence of ammonia enhanced the removal efficiency of 
FLU by FeVI and FeV. The reason was proposed to be the formation of higher reactive 
FeVI-ammonia and FeV-ammonia complexes than un-complexed ferrate species. 
Mechanical analysis indicated that these complexes reacted faster at the double bond 
moiety of the quinolone ring of FLU. 
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1. INTRODUCTION 
1.1. Micropollutants in the water environment 
During the past few decades, the research focus in the environmental field has 
been partly transferred from the traditional persistent and priority pollutants such as 
polychlorinated biphenyls and polycyclic aromatic hydrocarbons to the emerging micro-
contaminants (Carraro, et al., 2016; Hu, et al., 2017). Among them, pharmaceutical 
residues, personal care products, and endocrine disrupting chemicals are the most 
important classes.   Additionally, some hepatotoxic, cytotoxic, and/or neurotoxic 
cyanotoxins, released by cyanobacteria blooms, have also emerged as a significant 
concern to public health and the environment.   These micropollutants are frequently 
detected in water and wastewater at concentrations ranging from ng/L to μg/L.  These 
contaminants pose adverse ecological and human health effects (Jiang, et al., 2013; Luo, 
et al., 2014). Notably, some of them have been identified as persistent or pseudo-
persistent contaminants of concern due to their continuous release into the environment 
and to their bioaccumulative potential in aquatic species (Li, 2014; Ruhi, et al., 2016). 
Therefore, searching for effective treatments to remove these contaminants has attracted 
increasing attention worldwide. In this thesis, mitigation of the most well-known 
cyanotoxin, named microcystin-LR (MC-LR), and two representative antibiotics, i.e., 
sulfadiazine (SDZ) and flumequine (FLU), in water was sought. 
Chlorination, chloramination, and ozonation methods have been widely utilized 
to eliminate emerging pollutants during conventional water and wastewater treatments 
(Luo, et al., 2014; Postigo and Richardson, 2014). However, these processes can produce 
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disinfection byproducts, which can pose adverse effects on the public health. More 
recently, iron-based oxidants, namely ferrates, have garnered considerable attention 
owing to their high redox potential and subsequent coagulation/precipitation property as 
ferric hydroxide (Sharma, et al., 2015, 2016a). Ferrates are also superior to the 
aforementioned traditional technologies in that they have powerful disinfection 
properties to inactivate a wide range of bacteria and viruses.  Additionally, the removal 
of natural organic matter or disinfection byproduct precursors and heavy metals using 
ferrates can also be achieved (Sharma et al., 2015, 2016a).  The basic properties of 
ferrates and their effectiveness to treat a wide range of pollutants are given in the next 
section. 
1.2. Chemistry and application of ferrates 
Iron, which is one of the most common elements in the earth’s crust, performs 
very important roles in many fields ranging from biological oxidation processes to 
industrial production. Iron has a wide range of oxidation states, ranging from −2 to +6. 
In low oxidation states, such as +2 and +3, iron as a catalyst can catalyze iron-centered 
reactions including hydroxylation, hydrogenation, additions to carboxylic substrates, and 
nucleophilic substitutions (Sharma, et al., 2015, 2016a). High oxidation states of iron are 
believed to participate in the biological oxidation process in living organisms. In recently 
years, several studies have been performed to study the mechanisms of a couple of 
different nonheme and heme enzymes, including cytochrome P450 and chloroperoxidase 
(Prat et al., 2011). The results indicated that high-valent iron species, Fe(V) and Fe(IV), 
were involved in the catalytic process by facilitating the oxidation reaction of 
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hydrocarbons. Based on this research, it is believed that the oxidation reactivity of high-
valent iron compounds is determined by the structures of the ligands and the oxidation 
states of the iron centers. These high oxidation states of irons can also be involved in 
others reactions, such as cyclization, decarboxylation, and epoxidation reactions. 
(Sharma et al., 2015). 
In the last few years, research on high-valent tetraoxy iron species, which are 
commonly called ferrates (FeVIO4
2−, FeVI; FeVO4
3−, FeV; and FeIVO4
4−, FeIV) in an 
aqueous environment, has been explored for a wide range of applications in waste 
remediation, energy materials, and green organic synthesis. For example, FeVI is 
suggested as a greener oxidant agent in the synthetic organic chemistry due to its 
capability of hydrocarbon bond activation and selectivity. Thus, hydrocarbons can be 
hydroxylated and alcohols can be transformed to ketone by means of a high-valent state 
of iron species (Sharma, 2002b). FeVIO4
2- has been used in the decomposing of 
pharmaceuticals and personal care products (PPCPs) and endocrine disrupting chemicals 
(EDCs) in surface water (Karlesa, et al., 2014; Lee, et al., 2005; Lee, et al., 2009; Yang, 
et al., 2012; Yang, et al., 2014; Yang, et al., 2016). Applications of FeVI in degrading 
organosulfur compounds, amines, phenols, carboxylic acids, alcohols, carbohydrates and 
sucralose, ascorbate, hydrocarbons, and DNA and its constituents, biological species has 
also been demonstrated (Carr, 2008; Lee, et al., 2004; Noorhasan, et al., 2008; Sharma, 
2013; Sharma, et al., 2013, 2016a). 
In the water and waste water treatment field, only FeVIO4
2- was widely studied, 
while for FeVO4
3-, and FeIVO4
4-, only a handful of studies are available due to their short 
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lives in aqueous solutions. FeVIO4
2- is a promising water and wastewater treatment 
reagent. Although it has not been applied in water treatment plants due to its lower 
stability in aqueous solution/form and higher cost when compared with permanganate 
and chlorine, its application prospects are also promising. In the following sections, 
basic characterization and properties of ferrates are summarized. 
 Mössbauer spectroscopy, which is known as nuclear gamma resonance 
spectroscopy, is a versatile technique based on the Mössbauer effect (Kopelev, 1997). 
The Mössbauer effect, which was first described by Mössbauer in 1958, involves the 
occurrence of recoilless nuclear resonance absorption, and the emission of gamma-
radiation in a solid phase. This finding resulted in the development of the capability of 
Mössbauer spectroscopy to characterize a nucleus with chemical and environmental 
changes. This technique can be used in several different fields, such as chemistry and 
physics, to provide accurate information about material properties (Sharma, et al., 2015; 
Sharma and Zboril, 2015). 
One of the very useful applications of Mössbauer spectroscopy is based on the 
fact that it can readily recognize different oxidation states of iron in compounds of 
ferrates species (FeVIO4
2-, FeVO4
3-, and FeIVO4
4-) in their solid phases, based on the value 
of the isomer shift. Fig. 1.1 shows the Mössbauer spectroscopy measurements of 
ferrates. When oxidation states of iron increase, the values of the isomer shift decrease. 
The area of blue color represents a Mössbauer spectrum of FeVI, where the value of the 
isomer shift is -0.90 mm/s; the yellow color area is a Mössbauer spectrum of FeV, where 
the isomer shift of Fe (V) is -0.54 mm/s; the pink color area is a Mössbauer spectrum of 
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FeIV, and its isomer shift is -0.22 mm/s. 
 Ultraviolet-visible spectroscopy is a widely used method of identifying different 
analytes in chemical research. Aquatic analytes, such as transition metal ions in solution, 
can be identified based on the maximum absorption of ultraviolet-visible light 
spectroscopy. The quantity of analytes can also be determined based on the Beer-Lamber 
law. The concentration of the analyte in the solution is directly proportional to the 
absorbance of the solution. Fig. 1.2 shows the spectra of FeVI, FeV, and FeIV in visible 
regions. A red line represents the spectra of FeVI, which has a maximum absorbance at 
510 nm; A green line represents the spectra of FeV with a maximum absorbance at 380 
nm. A blue line represents the spectra of FeIV, which has a maximum absorbance at 430 
nm. 
 
Fig. 1.1. Mossbauer spectroscopy measurement of iron in different oxidation states of 
iron. Reprinted from Sharma et al. (2015) 
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Fig. 1.2. Visible spectroscopy measurements of ferrate species in aqueous solution. 
Reprinted from Rush and Bielski (1986). 
Acid-base equilibrium of FeVI and FeV species are represented by Eqs. 1.1-1.6. 
H3Fe
VIO4
+ ⇌ H+ + H2FeVIO4  pKa1 = 1.6 ± 0.2 (Cavazza, et al., 2010)  (1.1) 
H2Fe
VIO4   ⇌ H+ + HFeVIO4-  pKa2 = 3.5 (Bernasconi, et al., 2007)  (1.2) 
HFeVIO4
-   ⇌ H+ + FeVIO42-  pKa3 = 7.3 ± 0.1 (Chanda, et al., 2006) (1.3) 
H3Fe
VO4  ⇌ H+ + H2FeVO4- 5.5  pKa1  6.5 (Cataldo, et al., 2011) (1.4) 
H2Fe
VO4
- ⇌ H+ + HFeVO42- pKa2  7.2 (Cataldo, et al., 2011)  (1.5) 
HFeVO4
2- ⇌ H+ + FeVO43- pKa3 = 10.1 (Rush and Bielski, 1989) (1.6) 
In the pH range from alkaline to acidic conditions, FeVI has four different 
species, including deprotonated, monoprotonated, diprotonated, and triprotonated 
species, as well as FeV. The values of pKa have been applied to evaluate the speciation of 
the ferrate species (Fig. 1.3). Fig. 1.3 suggests a right shift of ~ 3 - 4 pH units in the 
speciation of ferrate species when the oxidation state of iron changes from +6 to +5. The 
fraction of speciation of the ferrate species in different pH conditions can be determined 
based on the pKa values. In a basic condition, FeVI has two major species ( and ), and 
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FeV has three major species. The pKa values of each FeVI species are lower than the 
counterpart pKa values of each Fe(V) species, which means that the proton releases of 
protonated FeV species are more difficult than the proton releases of protonated FeVI 
species. 
The redox potentials of FeVIO4
2-, FeVO4
3-, and FeIVO4
4- have been suggested to be 
pH dependent (Sharma, 2013). FeVI shows a high oxidation potential in acidic conditions 
compared to its oxidation potential in basic conditions. The redox potential of Fe(VI) in 
an acidic condition and in a basic condition are 2.20 and 0.70, respectively (Wood, 
1958). At an acidic pH, the redox potential of FeVIO4
2- is the highest one among 
hypochlorite, chlorine dioxide, ozone, and permanganate. Under basic conditions, the 
redox potential order is as follows: ozone > chlorine dioxide > hypochlorite > Fe(VI) > 
permanganate. The FeIII end product of FeVIO4
2- can also been used as a coagulant for 
further removal of organics, metals, and bacteria in water. FeVIO4
2- has been reported as 
an effective oxidant for persistent compounds, micropollutants, bacteria, viruses, heavy 
metals, and arsenic in water (Sharma, et al., 2015, 2016a). The focus of the present 
research is on the oxidation of microcystin-LR (MC-LR), sulfadiazine (SDZ), and 
flumequine (FLU). The sections below discuss human and health aspects of these 
micropolutants. 
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Fig. 1.3. Speciation of FeVI and FeV. Reprinted from Sharma (2013). 
1.3.  Microcystin-LR 
The molecular structure of MC-LR contains three D-amino acids, alanine (Ala), 
methyl aspartic acid (MeAsp), and glutamic acid (Glu); two unusual amino acids (3-
amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoicacid (Adda), and N-
methyldehydroalanine (Mdha); and two L-amino acids (leucine, Leu and arginine,  Arg) 
(Fig. 1.4). Below is a description of the potential effects of MC-LR on public and 
ecological health. 
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1.3.1. Metabolism of microcystin-LR in humans 
 Microcystin-LR is one of the most frequently detected cyanotoxins in the world. 
It is a tumor promoter and is hepatotoxic. Pathways of the metabolism of MC-LR in 
humans are shown in Fig. 1.5. Microcystin-LR may be metabolized via a glutathione 
conjugation pathway (Šetlíková and Wiegand, 2009). This conjugation of glutathione 
with microcystin-LR can be performed by catalysis of glutathione-S-transferases in rats 
(Takenaka, 2001). It has been confirmed that human glutathione-S-transferases, such as 
T1-1, P1-1, and M1-1, can also catalyze this conjugation reaction to form a glutathione 
adduct and is called a microcystin-LR-glutathione conjugation (Buratti, et al., 2011). The 
conjugation reaction of glutathione with microcystin-LR starts with the nucleophilic 
reaction of the sulfur of the glutathione to the carbon double bond of the Mdha moiety of 
microcystin-LR; a glutathione and cysteine adduct has been reported in mice (Kondo, et 
al., 1992). 
Initially, microcystin-LR is metabolized by a conjugation reaction of the double 
bond on the Mdha moiety of microcystin-LR to glutathione, and which results in a 
glutathione conjugate of microcystin-LR. Glutathione-S-transferase is involved in this 
reaction. Then, the microcystin-LR-cysteine-glycine conjugate is formed when the 
glutamic acid group of the microcystin-LR-cysteine-glycine conjugate is eliminated by 
glutamyltransferase. The microcystin-LR-cysteine conjugate is then formed after the 
removal of the glycine group of the microcystin-LR-cysteine-glucine conjugate. Finally, 
the microcystin-LR-mercapturic acid conjugate is produced by the oxidation of the 
microcystin-LR-cysteine conjugate by acetyl tranferase (Schmidt, et al., 2014). 
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Fig. 1.4.  Molecular structure of microcystin-LR. 
 
Fig. 1.5. The figure above shows the metabolism of microcystin-LR via the glutathione 
pathway in humans. Reprinted from Schmidt et al. (2014). 
1.3.2. Mechanism of microcystin-LR toxicity 
 Microcystins can cause inhibition of a class of enzymes called protein 
phosphatases (PP1 and PP2A) (Craig, et al., 1996). This type of inhibition, which leads 
to the build-up of phosphorylated proteins, is regarded as a mechanism by which 
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microcystins devastate livers. Fig. 1.6 shows a surface structure of PP1 (Goldberg, et al., 
1995). MC-LR binds to protein phosphatases such as PP-1c by way of interactions at 
three locations of the enzyme, including the C-terminal groove, the hydrophobic groove, 
and the catalytic location (Goldberg, et al., 1995). 
Interactions at the catalytic site: MC-LR combines indirectly with the two 
catalytic metal atoms by means of two water molecules across the carboxyl group of the 
glutamic acid and the adjacent carbonyl oxygen of the toxin (Goldberg, et al., 1995).  
The carboxyl group of the glutamic acid of microcystin is imperatively compulsory for 
toxicity by the peptide inhibitor in cycles. Moreover, since the carboxyl group of the 
Masp of MC-LR has interplay with Arg-96 and Tyr-134 of PP- 1 (Fig. 1.7), in 
consequence, MC-LR totally obstructs entry into the active center of the enzyme PP-1 
(Dawson and Holmes, 1999). 
 
Fig. 1.6. The surface of enzyme PP-1. Reprinted from Goldberg et al. (1995). 
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Fig. 1.7. Stereo view of microcystin-LR at the active site of PP-1. Reprinted from 
Goldberg et al. (1995). 
Interactions at the C-terminal groove: It is demonstrated that MC-LR 
interactions with the C- terminal groove of the PP-1 enzyme occur when this toxin 
inhibits PP-1. The crystal structure illustrates that Tyr-272 remains close to the leucine 
of MC-LR. That accounts for biochemical evidence that PP-1c sensitivity to MC-LR is 
on the decrease during the mutation of Tyr-272, particularly during the replacement of 
the aromatic moiety of Tyr-272 (Goldberg, et al., 1995). The covalent connection 
between the Mdha side chain of the toxin and Cys-273 of PP-1 was also noticed in the 
structure of the crystal. The terminal carbon atom of the Mdha connected with the S 
atom of Cys 273 and then produced a covalent linkage (Dawson and Holmes, 1999). 
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Interactions at the hydrophobic groove: The Adda chain of MC-LR packs into 
the hydrophobic groove. The package of the Adda group to the PP-1 hydrophobic 
groove remains fairly close, implying that a considerable part of the binding potential for 
the toxin is obtained from hydrophobic interactions in the area (Dawson and Holmes, 
1999). The result of adjustments in the Adda side chain has indicated that the whole 
form of the Adda chain is critical to the microcystin interaction. Geometrical isomers of 
microcystins, in which the diene double-bond on the Adda chain is altered from an 
expanded trans E configuration to the cis Z configuration, had reduced toxicity to a large 
extent. The toxicity might have been reduced when the diene double-bond on the Adda 
chain of the MC-LR was altered from a trans E configuration to the cis Z configuration. 
The toxicity test confirmed that the toxicity in IC50 of the toxins reduced 100-fold 
(Nishiwaki-Matsushima, et al., 1991). 
Other microcystin species, such as microcystins-LA, microcystin-RR and 
microcystin-YR, have the same toxicity mechanism in that they can inhibit the same 
phosphatases and result in histological changes in rodent livers (Dawson and Holmes, 
1999), with a mechanism similar to that of microcystin-LR. This mechanism proves that 
microcystin serves as an inhibitor of the activity of PP1 by obstructing substrate binding 
to the active center of the enzyme in a direct manner. 
1.3.3. Microcystin at the level of the cell 
 Microcystin attaches exclusively to the protein phosphatases such as PP1 and 
PP2A, blocking them and resulting in a cluster of events triggering cell death (Fig. 1.8) 
(Valério, et al., 2010). By the blockage of PP1 and PP2A, microcystin seemingly keeps 
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some cellular processes under control. Microcystin can activate CaMKII, the calcium-
calmodulin-dependent multifunctional protein kinase II, which may lead to ROS 
formation; Nek2 kinase, which takes part in the constraint of mitotic progression and 
chromosome segregation, can be activated by microcystin. This type of interplay can 
lead to cellular viability and tumorous growth; microcystin may regulate the expression 
of mitogen-activated protein kinases’ (MAPKs) via the inhibition of PP-2A. MAPKs 
regulate several cellular activities, including proliferation and cell apoptosis (Valério, et 
al., 2010). 
Moreover, the nuclear phosphoprotein P53 increases after microcystin exposure. 
P53 regulates the expression of the pro- and anti-apoptotic genes inclusive of Bax and 
Bid that are members of the Bcl-2 family. Bax and Bid play a pivotal role in the process 
of apoptosis, particularly in the mitochondria-dependent pathway. Research reveal that 
microcystin-LR makes P53 active by the blockage of PP2A, leading to a disequilibrium 
in the ratio of pro/anti-apoptotic members of the Bcl-2 family, giving rise to a pore 
opening through mitochondrial permeability and the discharge of apoptotic proteins into 
the cytosol, provoking caspase cascade activation and, in the end, apoptosis. The 
mitochondrial pathway is viewed as an essential pathway in MC-LR-induced apoptosis. 
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Fig. 1.8. The mechanisms of microcystins toxicity in cell. Reprinted from Valério et al. 
(2010). 
1.3.4. Microcystin in the body at the organ level 
 Most oral and injection studies in laboratory animals have shown that the liver is 
a primary target organ for microcystin toxicity. Based on the results of these studies, 
death might occur as soon as a few hours after the injection of microcystins (Woolbright, 
et al., 2017). A large proportion of the understanding regarding the toxicity of 
microcystins is founded upon research with mice and rats which were given intra-
peritoneal (IP) injections of MC-LR; that is to say, injections were administered into the 
abdominal cavity in a direct manner (Meneely and Elliott, 2013). 
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Manifestations of liver damage at early stages consist of an increase of liver 
enzymes in the serum, a sign that is symbolic of liver cell death, as well as extra liver 
weight due to intrahepatic hemodynamic shock (Chen, et al., 2016; Hu, et al., 2016). 
Then it leads to heart failure and death. Liver damage and cell death are likely to be 
watched microscopically 20 minutes after giving an injection containing a lethal dose of 
MC-LR. In sixty minutes, hepatocytes come to an end, their linkage to one another falls 
apart, and the normal architecture of the liver is shattered. 
The main toxicity mechanism of microcystins is to block a type of enzyme 
referred to as a protein phosphatase. The function of these enzymes is to regulate the 
phosphorylation process, which results in the removal of phosphate from a protein 
(Máthé, et al., 2016). This inhibition of protein phosphatases by microcystins is believed 
to be the main mechanism of liver damage. Hepatocytes derived from animals which are 
treated with microcystins seem to draw to a close by cell suicide or a process of 
programmed cell death that is known as apoptosis. Cells which go through apoptosis 
vanish in a characteristic fashion, consuming their own cellular organelles. Other 
microcystin species, such as microcystins-LA, microcystin-RR and microcystin-YR, 
have the same toxicity mechanism in that they can block the same phosphatases and 
result in alterations related to histology in rodent liver, which is similar to the 
mechanism of microcystin-LR. 
1.3.5  Public health impact of microcystin on humans 
 The cyanotoxins known as microcystins have brought about human intoxication 
events across the globe. The reported issues regarding health are most possibly 
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associated with microcystin exposure in long-term and low level concentrations due to 
the use of polluted food (agricultural products, and freshwater fish) and water (river, 
ponds and lakes), exposure through the skin, and breathing. In human beings, the most 
affected organ is the liver; other tissues and organs, such as kidneys and colon, can also 
be affected by exposure to the toxin (Fig. 1.9) (Rastogi, et al., 2014). In consequence, the 
health effects resulting from microcystin intoxication are liver and gastroenteritis illness 
(Zanchett and Oliveira-Filho, 2013).  
Exposure to cyanobacterial toxins by using polluted drinking water has led to 
significant cases of poisoning in human beings, even causing deaths. As a result, in 1997 
the World Health Organization set a temporary reference value of 1 μg/L for MC-LR in 
drinking water (Hudder, et al., 2007; Sharma, et al., 2012). Apart from the mouth, there 
also exists the likelihood of the parenteral route of exposure, when surface water full of 
cyanobacteria, utilized for the purpose of hemodialysis, enters the blood and 
consequently threatens patients’ lives. The first authenticated occurrence of human 
poisoning related to cyanotoxins came to pass in Caruaru, Brazil in 1996, when patients 
who received renal dialysis treatment in a routine manner started to complain of 
vomiting, blurred vision, eye pain, headache, and other symptoms. Because of the use of 
water polluted by cyanotoxins (Freitas de Magalhães, et al., 2001), 76 patients 
succumbed to liver complications. An analysis was conducted, and it proved that in the 
clinic’s water purification system, microcystins existed in activated carbon. In patients’ 
liver and blood, microcystins were discovered. There are many other cases which have 
been publicized about human intoxication because of the dissolution of cyanotoxins in 
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water. An additional episode took place in Brazil, in which intoxication was ascribed to 
blooms from Microcystis and Anabaena species, and there were identified 88 deaths and 
2000 confirmed cases of gastroenteritis within just 42 days (Ferrão-Filho and 
Kozlowsky-Suzuki, 2011; Rastogi, et al., 2014).  
 
Fig. 1.9. Health concerns of microcystin and ecology. Reprinted from Rastogi et al. 
(2014). 
However, in addition to possible human contamination by way of the water 
supply, it is also possible for contamination to occur through the food chain. In quite a 
few studies the bioaccumulation of cyanotoxins and their transfer via the food web has 
been authenticated. It is likely that these toxins affect human beings following their 
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consumption of aquatic food, such as fish. Some fish, such as carp and tilapia, are likely 
to consume cyanobacterial cells containing toxins in water, thereby gathering them in the 
muscles, liver, kidney, and viscera.  
Besides the acute health impact brought about by cyanotoxins, long-time 
exposure to low doses of cyanotoxins is likely to result in the development of cancer and 
in human beings. Cancer is viewed as a predominant public health issue all over the 
world and is deemed the chief causes of mortality globally. The death rate is increasing 
with alterations in lifestyle and nutrition and with the worsening of global warming. It 
was estimated by the American Cancer Society that there were 7.6 million people who 
lost their lives to cancer the world over in 2007. The announcement that hepatotoxins 
produced by cyanobacteria lead to the inhibition of protein phosphatase has intimated 
alarmingly that human exposure to non-lethal doses of these toxins is likely to function 
as a contributor to the development of cancer. In the past few months, the International 
Agency for Research on Cancer (IARC) has registered microcystin-LR as a possible 
carcinogen for human beings (Group 2B). 
In epidemiological investigations, an association has been established between 
the increased incidence of cancer and drinking water sources that are possibly polluted 
with microcystins in parts of China, where the rate of human hepatocellular carcinoma is 
one of the highest across the globe and differs from region to region. It has been 
observed that the highest cancer mortality rates are in areas where drinking water comes 
from ponds and ditches, in comparison with lower incidence in areas where drinking 
water issues from deep wells. 
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1.3.6. Public health impact of microcystin on ecological systems 
Cyanobacteria and their poison can affect various species ranging from plants, 
algae and bacteria to more complex life forms, and their influence on aquatic 
invertebrates, especially zooplankton, have drawn particular attention. The zooplankton 
society structure can be affected by cyanotoxins, in particular when their food 
phytoplankton is dominated by cyanobacteria. 
In the meantime, scientists also observed the untoward influences of the intake of 
microcystins by hydrobios. Experts have studied the intestinal absorption and influence 
of ingestion of microcystins of Daphnia galeata. Daphnia was placed in microcystins 
and its movements, intestine structure, microcystin density in blood, and external form 
were observed periodically (Herrera, et al., 2015). This observation has shown that the 
intake of microcystins led to fatal poisoning, so that a 1 mg weight of Daphnia galeata, 
which absorbed from 10.2 to 18.3 ng of microcystin, would die instantly. 
Also, researchers investigated the influence of microcystins on Daphnia magna, 
which verified the fact that when injected into a high level of microcystins and exposed 
for, Daphnia magna would suffer fatal consequences, since microcystins started to 
accrue and restrain the enzyme phosphatase in the course of lasting exposure; on the 
contrary, it was noted that only low doses of microcystins cannot induce any toxic 
consequence (Ger, et al., 2014). 
In addition, some other species such as cyanobacteria, daphnids, algae, plants, 
and diatoms as well as can also be influenced by cyanotoxins (Backer, et al., 2015). 
When exposed to MC-LR, photosynthesis and growing can be restrained in the 
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Anabaena and cyanobacteria Nostoc muscorum. The sub-aquatic plant, Ceratophyllum 
demersum, is also influenced by microcystin-LR, performing so that when infected into 
with 1.0 μg L-1
 
of microcystin-LR for 6 weeks, its growth would slow down, and a 
density of 5 μg L-1 of MC-LR can lead to the same marked shrinkage in growth after 
only 3 weeks (Romero-Oliva, et al., 2015; Szigeti, et al., 2010). Mollusks can also be 
influenced by cyanotoxins. It has been reported that exposure to microcystin-LR might 
result in a modest accumulation within the tissues of the gastropod pulmonate Lymnaea 
stagnalis (Lance, et al., 2010). 
In addition to the influence of cyanobacteria on aquatic invertebrates, fish will be 
also injured by cyanobacteria, which can be supported by a histopathological study of 
deceased fish in cyanobacterial flowers (Botana, 2016; Zanchett and Oliveira-Filho, 
2013). This pointed to the injury by cyanobacteria to the liver, alimentary canal, and gills 
as possibly the chief reason for fish death. Another possibility is that injury of the gill 
can increase the microcystin intake and thereby cause liver necrosis. Other pathological 
features of poisonous cyanobacterial flowers included impairment to the heart, liver, 
kidneys, gills, spleen and skin. 
It is likely that some fish, particularly phytoplanktivorous types, can absorb 
microcystins when being fed, or via some passive approaches by which poisons can go 
through the gills when respiring. For young fish, they are usually susceptible to 
poisonous substances. In case of the adult fishes, the thin epithelium and fairly large 
surface, together with a high metabolism rate, results in their damage by microcystins. 
This injury tends to cause death, especially during the major growth stage of the fish. 
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The toxicity of microcystins in the embryolarval development of carp, Cyprinus 
carpio, has been studied (Drobac, et al., 2016). The results affirmed that exposure to 
microcystins showed embryotoxic effects such as significant fish mortality. 
Also, scientists have studied the influence of microcystin on yearling rainbow 
trout in which microcystin was placed intraperitoneally or which was soaked in water 
with algae (Svircev, et al., 2015). The rainbow trout absorbed microcystin chiefly by 
liver, and when the toxin arrived at the liver, it would lead to large-scale hepatic 
necrosis.  Ibelings et al. (2005) have found that the amount of microcystin is particularly 
great inside the liver of planktivorous fish, which then places birds which took the fish 
as food at high danger. They also pointed out that 80 percent of zooplankton samples 
and 89 percent of samples of Dreissena polymorpha contained microcystins (Ibelings, et 
al., 2005). Hence, the conclusion was drawn that microcystin can indeed travel through 
the food link, in spite of the deficiency of bio-magnification. 
1.4.  Sulfadiazine 
Sulfadiazine (SDZ) is 4-amino-N-(2-pyrimidinyl) benzenesulfonamide) (Fig. 
1.10). SDZ is one of the most widely used sulfonamide antibiotics due to its extensive 
utilization for humans and livestock. It is commonly detected in aquatic environments 
because of its resistance to biodegradation and persistence in the natural environment 
(Gothwal and Shashidhar, 2015). Recently, the concerns regarding the occurrence of 
SDZ as well as other antibiotics in aquatic environments have attracted increasing 
attention. The biological activity of sulfonamide residues in the aquatic ecosystem may 
contribute to the growth of antibiotic resistance in microbial communities, which is 
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believed to be a worldwide issue of human health. SDZ has been detected in aquatic 
environments globally. The concentration range of sulfadiazine is from ng/L to µg/L. 
The maximum concentration of sulfadiazine was up to 4.13 µg/L, which was identified 
in surface water in the UK (Boxall, et al., 2012). Among the various antibiotics, 
sulfadiazine is one of the most commonly detected sulfonamides in China. More details 
on SDZ are in Section 4. 
 
Fig. 1.10. Molecular structure of sulfadiazine (SDZ). 
1.5. Flumequine 
 Currently, more than 5000 different pharmaceutical compounds have been on the 
market worldwide for intended use for human and veterinary applications (Dorival-
García, et al., 2013). These pharmaceuticals continue to be released into the 
environment, resulting in great concerns due to their potential effects on human health 
and biota.(Barbosa, et al., 2016; Van Doorslaer, et al., 2014). There has been an increase 
in the consumption of antibiotics due to the increase in population worldwide and the 
aging of people in developed countries (Khetan and Collins, 2007). Among antibiotics, 
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luoroquinolones (FQs) are of tremendous significance because they are wide spectrum 
antibacterials with an increasing use in veterinary and household applications 
(Chierentin and Salgado, 2016; Rutgersson, et al., 2014). Fluoroquinolone antibiotics are 
applied as treatment for bacterial infections in animals and humans (Chierentin and 
Salgado, 2016; Rutgersson, et al., 2014). Interestingly, FQs account for a 17% share of 
the global market (Hamad, 2010). Significantly, FQs antibiotics are excreted 
unmetabolized (≤ 70%) (Tran, et al., 2016). Hence, their release into the environment 
promotes antibiotic resistant bacteria and antibiotic resistant genes (Cizmas, et al., 2015; 
Sharma, et al., 2016b). The research presented herein deals with flumequine (FLU), 
which is a class of fluroquinolone antibiotics (Fig. 1.11). More details on FLU are 
provided in Section 5. 
 
Fig. 1.11.  Structure of flumequine. 
1.6. Remediation methods 
Conventional water treatment technologies include membrane separation, 
coagulation, sedimentation, and activated carbon adsorption (Campinas and Rosa, 2010; 
Lee and Walker, 2008; Pavagadhi, et al., 2013; Sun, et al., 2012; Teixeira and Rosa, 
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2005).  These methods are not effective in removing MC-LR, particularly as it cannot be 
removed methodically from the environment. Other alternate treatments include 
oxidation by advanced oxidation processes (AOP) and chemical oxidants (He, et al., 
2015; Sharma, et al., 2012). These processes are TiO2/UV, modified-TiO2/visible light, 
ultrasound irradiation, and Fenton and photo-Fenton systems (De Freitas, et al., 2013; 
Eskandarian, et al., 2016; Fotiou, et al., 2016; Rajasekhar, et al., 2012). AOPs generally 
generate hydroxide radicals (•OH) and sulfate radicals (SO4
-•), which can degrade MC-
LR efficiently in water (Antoniou, et al., 2010; Song, et al., 2009). Chlorine, chloramine, 
ozone, and permanganate are examples of chemical oxidants (Acero, et al., 2008; Liu, et 
al., 2009; Miao, et al., 2010; Wert, et al., 2014). Chlorination can easily degrade MC-
LR, but it produces potentially toxic chlorinated byproducts (Zhang, et al., 2016; Zong, 
et al., 2015). Chloramine is not able to oxidize MC-LR.   Ozone and permanganate are 
capable of degrading MC-LR (Acero, et al., 2008; Miao, et al., 2010; Rodríguez, et al., 
2007). This paper deals with tetra-oxy iron(VI) anion (FeVIO4
2-), commonly called 
ferrate(VI) (FeVI), which can address concerns with byproducts (Sharma, et al., 2015, 
2016a). For example, Fe(VI) does not react with the bromide ion and thus does not 
directly form the carcinogenic bromate (BrO3
-) ion (Sharma, 2010). FeVI as a preoxidant 
also decreased the level of disinfection byproducts during chlorination (Gan, et al., 2015; 
Yang, et al., 2015). Added advantages are that FeVI is simultaneously carrying out 
disinfection and coagulation to inactivate microorganisms and is removing toxic metals, 
respectively (Prucek, et al., 2015; Sharma, 2007). Applications of FeV and FeIV to treat 
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pollutants have also been forthcoming in recent years (Kralchevska, et al., 2016; 
Machalová Šišková, et al., 2016; Sharma, et al., 2008, 2015, 2016a). 
In this thesis research, transformations of MC-LR, SDZ, and FLU by FeVI, FeV, 
and FeIV were carried out. Aims of the research are presented in Chapters 2, 3, 4, and 5. 
Results of the research are described in these chapters. Section 6 concludes the 
objectives achieved in the research. The future outlook for research in this area is also 
presented in Section 6. 
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2. OXIDATION OF MICROCYSTIN-LR BY FERRATE(VI), FERRATE(V), AND 
FERRATE(IV): DEGRADATION PRODUCTS 
2.1.  Introduction 
The occurrence of blue-green algal (cyanobacterial) blooms is a worldwide 
phenomenon.  Environmental conditions that facilitate the formation of blooms include a 
water temperature range of 15 – 30o C, a pH level between 6 and 9, and moderate to high 
levels of phosphorous and nitrate or ammonia (Sharma, et al., 2012, 2017). The toxic 
form of cyanobacterium Microcystis aeruginosa in the waters of China, Japan, Norway, 
South Africa, the United Kingdom, the United States, and Canada have been suggested 
(Sharma, et al., 2012, 2017). The generation of toxin-producing cyanobacteria in water 
resources is a growing global issue because these toxins affect human population 
through drinking water.  Species of strains that produce cyanotoxins include 
microcystins (MCs), cylindropermopsin (CYN), saxitoxins, and anatoxins .  These 
species can affect neurological systems (Craig, et al., 1996).  Reports also suggested that 
the species can also be potential genotoxins, carcinogens, and inhibitors of protein 
synthase (Valério, et al., 2010).  In certain cases, fatal intoxication of the human 
population from cyanobacterial species has occurred (Woolbright, et al., 2017).  
Moreover, cyanobacteria are capable of producing metabolites (e.g. 2-methylisoborneol 
and geosmin), which cause problems of unpalatability of water due to taste and odor 
problems (Gurbuz, et al., 2016; Weirich and Miller, 2014).  This chapter deals with the 
mitigation of one of the microcystins, microcystin-LR (MC-LR), in water.  
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Microcystins (MCs), comprising a large group of cyclic heptapeptide toxins, are 
produced by cyanobacterial species such as Anabaenopsis Hapalosipon and Microcystis 
(Harke, et al., 2016). Contamination of water with MCs has become a serious public 
health and environmental safety concern due to frequent occurrence of blue-green algae 
(cyanobacteria) blooms in water (Gurbuz, et al., 2016; Weirich and Miller, 2014). A 
number of MCs (> 90) have been identified, which have a general structure consisting of 
D-alanine, γ-linked-D-glutamic acid, D-erythro-β-methylaspartic acid (Adda), N-methyl 
dehydroalanine, and two variable L-amino acids (Flores and Caixach, 2015; Qi, et al., 
2014). Microcystine-LR (MC-LR) contains leucine (L) and arginine (R) in positions 2 
and 4, respectively. In the past decade, MC-LR has received more attention because it 
has acute toxicity (He, et al., 2016; Zhou, et al., 2015), and it has been detected in waters 
of Asian and European countries as well as in water of North America (Gkelis and 
Zaoutsos, 2014; Lin, et al., 2016; Pick, 2016; Schmidt, et al., 2013). A guideline value 
for MC-LR in drinking water, recommended by the World Health Organization (WHO), 
is 1 µg/L (World Health Organization, 1997). Many treatment methods have been 
investigated to remove extracellular MC-LR from water (Sharma, et al., 2012, 2017). 
Conventional water treatment technologies include membrane separation, 
coagulation, sedimentation, and activated carbon adsorption (Campinas and Rosa, 2010; 
Lee and Walker, 2008; Pavagadhi, et al., 2013; Sun, et al., 2012; Teixeira and Rosa, 
2005).  These methods are not effective removing MC-LR; particularly, it cannot be 
removed methodically from the environment.  Other alternate treatments include 
oxidation by advanced oxidation processes (AOP) and chemical oxidants (He, et al., 
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2015; Sharma, et al., 2012). These processes are TiO2/UV, modified-TiO2/visible light, 
ultrasound irradiation, and Fenton and photo-Fenton systems (De Freitas, et al., 2013; 
Eskandarian, et al., 2016; Fotiou, et al., 2016; Rajasekhar, et al., 2012). AOPs generally 
generate hydroxide radicals (•OH) and sulfate radicals (SO4
-•), which can degrade MC-
LR efficiently in water (Antoniou, et al., 2010; Song, et al., 2009). Chlorine, chloramine, 
ozone, and permanganate are examples of chemical oxidants (Acero, et al., 2008; Liu, et 
al., 2009; Miao, et al., 2010; Wert, et al., 2014). Chlorination can easily degrade MC-
LR, but it produces potential toxic chlorinated byproducts (Zhang, et al., 2016; Zong, et 
al., 2015). Chloramine is not able to oxidize MC-LR. Ozone and permanganate are 
capable of degrading MC-LR (Acero, et al., 2008; Miao, et al., 2010; Rodríguez, et al., 
2007). This paper deals with a tetra-oxy iron(VI) anion (FeVIO4
2-), commonly called 
ferrate(VI) (FeVI), which can address concerns of byproducts (Sharma, et al., 2015, 
2016a). For example, Fe(VI) does not react with the bromide ion and thus does not 
directly form the carcinogenic bromate (BrO3
-) ion (Sharma, 2010). FeVI as a preoxidant 
also decreased the level of disinfection byproducts during chlorination (Gan, et al., 2015; 
Yang, et al., 2015). Added advantages of FeVI are simultaneous disinfection and 
coagulation to inactivate microorganisms and to remove toxic metals, respectively 
(Prucek, et al., 2015; Sharma, 2007). 
The research in the present chapter was stimulated by our previous finding of 
aromatic hydroxylation during the oxidation of MC-LR by FeVI (Jiang, et al., 2014). This 
was surprising because hydroxylation was observed in the oxidation of MC-LR by •OH 
radicals (Fotiou, et al., 2016). We invoked intermediate high-valent iron species, FeV and 
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FeIV during the oxidation of MC-LR by FeVI to induce the formation of hydroxylated 
derivatives of MC-LR. Recently, we were able to synthesize solid compounds of FeV 
(K3FeO4) and Fe
IV (Na4FeO4) (Kralchevska, et al., 2016; Machalová Šišková, et al., 
2016), which allowed us to demonstrate for the first time that FeV and FeIV could attack 
the benzene moiety to yield aromatic hydroxylation of MC-LR. The objectives of the 
current study were to (i) identify the transformation products of the oxidation of MC-LR 
by FeVI, FeV, and FeIV to learn the moieties of the parent molecule involved in oxidation, 
(ii) to learn the similarities and differences of the three high-valent iron species in 
reaction pathways to oxidize MC-LR by varying the concentrations of FeVI, FeV, and 
FeIV, and (iii) to evaluate the effectiveness of ferrates, based on the general trend of 
observed oxidized products from the oxidation by FeVI, FeV, and FeIV. 
2.2.  Experimental methods 
2.2.1 Chemicals 
 Sodium hydrogen phosphate (Na2HPO4), sodium hydroxide, and hydrochloric 
acid were purchased from Sigma-Aldrich (St. Louis, MO, USA) and Fisher Scientific 
(Austin, TX, USA). A solid powder of potassium ferrate (K2FeO4) with purity of > 98% 
was prepared by a wet chemical technique (Luo, et al., 2011). Potassium ferrate(V) 
(K3FeO4) and sodium ferrate(IV) (Na4FeO4) were the salts of Fe
V and FeIV species used 
in the study.  Both of these salts were synthesized by thermal techniques, and details are 
given elsewhere (Machalová Šišková, et al., 2016). The purities were tested by 57Fe 
Mössbauer spectroscopy (Machalová Šišková, et al., 2016; Yates, et al., 2014). The 
purity of solid K3FeO4 was 75 % and the remaining 25 % was Fe(VI). A solid powder of 
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Na4FeO4 was of high purity (>90 %). Salts of all the ferrate species were kept in a glove 
box, purged with nitrogen. A laboratory culture of Microcystis aeruginosa (CCMP299) 
was purified to obtain MC-LR (Song, et al., 2005). De-ionized water, before use in 
preparing solutions, was passed through an 18 MΩ cm Millipore water purification 
system (Waters Alliance, Milford, MA, USA). Solutions of MC-LR were prepared in a 
0.01 M phosphate buffer solution. The pH of the buffer solution was adjusted to pH 7.0 
using phosphoric acid. An Orion 720A pH meter and an Accumet pH probe were 
utilized to fix the pH of the solution to 7.0. 
2.2.2 Product studies 
In this study, a 10 mL solutions containing 5.0 µM MC-LR was prepared and 
placed in a glove box. Salts of FeVI, FeV, and FeIV species of different amounts were 
weighed in the anaerobic chamber of the glove box and immediately added into vials 
containing 10 mL of 5.0 µM MC-LR. The final concentrations of the three ferrate 
species in the mixtures were 200 µM, 400 µM, and 850 µM. The reaction of FeVI was 
allowed to occur until no pink violet color of the FeVI could be seen. The spectra of 
mixed FeVI and MC-LR solutions were run to make sure no Fe(VI) was present after the 
completion of the reaction. This mixed solution was filtered using a 0.45 μm filter before 
identifying the oxidized products. In studying the reactions between FeV and FeIV 
species with MC-LR, the mixed solutions were immediately subjected to the addition of 
hydroxylamine, a quenching reagent. The addition of a quenching reagent to FeV/FeIV 
and MC-LR mixed solutions was done in less than 10 s. The quenching reagent reacted 
rapidly with FeVI, so no significant reaction of FeVI with MC-LR could happen (Johnson 
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and Hornstein, 2003). A salt of FeV had an impurity of FeVI, which could interfere with 
the reaction of FeV with MC-LR.  Furthermore, both FeV and FeIV species also 
simultaneously reacted rapidly (Menton and Bielski, 1990; Rush and Bielski, 1989; Rush 
and Bielski, 1994)with the solvent of MC-LR solution (i.e., water) to give an FeVI ion 
(Yates, et al., 2014). Basically, a rapid addition of quenching reagent to the FeV/FeIV and 
MC-LR mixed solutions avoided any possible interference from the reaction of FeVI with 
MC-LR. This approach allowed us to study the products obtained only from the aimed-at 
reactions (FeV and MC-LR or FeIV-MC-LR). 
The concentration of MC-LR in the final mixed solutions were tested using a 
ThermoFisher HPLC system (Ultimate 3000) equipped with an autosampler and a 
photodiode array detector. A mobile phase used a mixture of 0.05 % (v/v) trifluoroacetic 
acid (TFA) in acetonitrile (40 %) and 0.1 % (v/v) TFA aqueous solutions (60 %). The 
stationary phase applied was a Luna RP C18 column (250×4.6 mm I.D., 5 μm). 
2.2.3 Analysis of oxidized products 
A high-resolution LC-MS/MS system was used to characterize the FeVI, FeV, and 
FeIV mediated oxidation products (OPs) of MC-LR. A QExactive mass spectrometer 
equipped with a Hypersil Gold column (100 mm × 2.1 mm, 3 µm) (Thermo Scientific, 
San Jose, CA, USA) and a Heated Electrospray Ionization source was used in the 
positive ionization mode to analyze OPs. The parameters of the analysis were: sheath 
gas flow: 30 arbitrary units; auxiliary gas flow: 20 arbitrary units; spray voltage: 4.4 kV; 
capillary temperature: 300 °C; heater temperature: 250 °C. Identification of the OPs was 
based on accurate mass measurements using a mass tolerance of 2 ppm. MS experiments 
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were performed at 17,500 resolutions using the following parameters: normalized 
collision energy (% NCE): 20-50; automatic gain control (AGC) target: 2×104, 
maximum injection time (IT): 40 ms; and isolation width: 2.0 m/z. The mobile phase in 
analyzing OPs was (A) acetonitrile and (B) 0.1 % formic acid in water. The gradient 
solution was 15-25 % A for 6 min followed by a linear increase to 40 % for 15 min and 
80 % for 20 min followed by a decrease to 15 % for 22 min, and held constant for an 
additional 3 min. 
2.3. Results and discussion 
 Transformation products of the oxidation of MC-LR by FeVI, FeV and FeIV were 
analyzed using their three different concentrations, namely high (H), medium (M), and 
low (L) concentrations of FeVI, FeV and FeIV. More details of their levels are given in the 
experimental section. For simplicity, different species are written as FeVI(L), FeVI(M), 
and FeVI(H) for FeVI species, FeV(L), FeV(M), and FeV(H) for FeV, and FeIV(L), FeIV(M), 
and FeIV(H) for FeIV species, for low, medium, and high concentrations of these ferrate 
species, respectively. 
An approach used in identifying the oxidized products (OPs) of MC-LR by FeVI, 
FeV, and FeIV species was similar to that used by other researchers to characterize the 
products obtained by other oxidation technologies such as ultrasonic, UV/H2O2, 
radiolysis, photocatalytic, sulfate radicals permanganate, and electrochemical (Huang, et 
al., 2008; Liao, et al., 2014; Liu, et al., 2003; Song, et al., 2006; Song, et al., 2007; Su, et 
al., 2013; Zhang, et al., 2013). The molecular formulas for the observed products were 
obtained by identifying the best match of the high-resolution mass spectral data 
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(observed) to the calculated exact masses (theoretical) of different molecular formulas 
(Table 2.1). The differences between the m/z of the experimental and the theoretical 
results for most of the OPs were ≤2.0 ppm (Table 2.1). Specific MS spectra and 
structures associated with each of the products are provided in Fig. 2.1-2.17. 
Quantitative determinations of OPs on the MS were not carried out because of the lack 
of products standards. 
Three different hydroxylated derivatives of MC-LR, with molecular weights 
(MWs) of 1028.5542, 1044.5492, and 1030.5699 were observed in the experiments with 
low concentrations of all three high-valent iron species (i.e., FeVI(L), FeV(L) and 
FeIV(L)) and medium concentrations of FeV, and FeIV (FeV(M) and FeIV(M)). The 
hydroxylated product with a MW of 1026.5386 was observed only in the experiment 
with FeVI(L). Three clearly resolved peaks with a MW of 1028.5542 correspond to the 
addition of two HO groups without the loss of H atoms (M+34). Dihydroxy-MC-LR 
could have two different structures, one that corresponds to the dihydroxylation at the 
conjugated pi system of the Adda moiety and its isomers, and another that relates to the 
dihydroxylation at the carbon−carbon double bond in the Mdha moiety. These proposed 
products have been reported in our previous study of the oxidation of MC-LR by FeVI 
species (Jiang, et al., 2014) and in other oxidation studies (Huang, et al., 2008; Liao, et 
al., 2014; Liu, et al., 2003; Song, et al., 2006; Song, et al., 2007; Su, et al., 2013; Zhang, 
et al., 2013). 
Simultaneous hydroxylation through the addition of two HO groups (M+34) and 
the substitution of hydrogen for an OH group at the aromatic ring in the Adda moiety 
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(M+16) results in a MW of 1044.5492 (M+50). In this study, the full scan chromatogram 
has three different peaks that could correspond to two main structures with different 
isomer variations. These product structures have also been proposed in other 
investigations, UV/H2O2 (Zong, et al., 2013), sulfate radicals (Antoniou, et al., 2010), 
permanganate (Huang, et al., 2008), and ultrasonic (Song, et al., 2006).  One structure 
was assigned to 1,2 and 1,4 di-hydroxylation at the Adda moiety plus the ortho, metha 
and para monohydroxylation in the benzene ring. Another structure was assigned to 
dihydroxylation at the carbon−carbon double bond in the Mdha moiety plus the ortho, 
metha and para monohydroxylation in the benzene ring. 
The structure corresponding to the MW of 1030.5699 was also reported in the 
oxidation of MC-LR carried out by ClO2 and TiO2-photocatalytic processes (Fotiou, et 
al., 2013; Kull, et al., 2004).  This product could be formed by hydration at two different 
vulnerable sites in MC-LR. One possibility is the double hydration of the double bonds 
in the Adda moiety. Another possibility is one hydration in the Adda chain plus one 
hydration in the Mdha chain. 
Double hydroxylation of the aromatic ring by the substitution of two hydrogens 
with two hydroxyl groups at the benzene ring is suggested for the structures 
corresponding to a MW of 1026.6386 (M+32). This product was observed in our 
previous findings of aromatic hydroxylation during the oxidation of MC-LR by FeVI 
(Jiang, et al., 2014). The OPs were further differentiated based on the degradation 
pathways described in the following three reaction schemes. 
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Table 2.1.  Mass and molecular formulas for the observed products, m/z experimental 
and theoretical, and mass error between theoretical and experimental m/z. 
 
Mass
Proposed 
formula
Theoretical 
m/z
a
Experimental 
m/z
b 
Mass error 
(ppm)
MC-LR 994.5488 C49H74N10O12 995.5560 995.5558 -0.20
P_1044 1044.5492 C49H76N10O15 1045.5564 1045.5560 -0.38
P_1030 1030.5699 C49H78N10O14 1031.5772 1031.5763 -1.16
P_1028 1028.5542 C49H76N10O14 1029.5615 1029.5608 -0.68
P_1026 1026.5386 C49H74N10O14 1027.5459 1027.5457 -0.19
P_1014 1014.5386 C48H74N10O14 1015.5459 1015.5452 -0.69
P_1008 1008.5280 C49H72N10O13 1009.5353 1009.5347 -0.59
P_964 964.5382 C48H72N10O11 965.5455 965.5450 -0.52
P_810 810.3872 C34H54N10O13 811.3945 811.3941 -0.49
P_794 794.3923 C34H54N10O12 795.3985 795.3994 1.13
P_782 782.3923 C33H54N10O12 783.3995 783.3992 -0.38
P_758 758.3923 C31H54N10O12 759.3995 759.3993 0.26
P_744 744.3766 C30H52N10O12 745.3839 745.3836 -0.40
P_742 742.3974 C31H54N10O11 743.4046 743.4046 0
P_704 704.2977 C27H44N8O14 705.3050 705.3051 0.14
P_674 674.3235 C27H46N8O12 675.3308 675.3305 -0.44
P_361 361.1889 C20H27NO5 362.1962 362.1964 0.55
P_345 345.1940 C20H27NO4 346.2013 346.2015 0.58
a
Calculated using ChemDraw 2010. 
b
Observed in Orbitrap mass spectrometer
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Fig. 2.1.  Mass spectra of P_1044. 
  
m/z 1045.5564 
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Fig. 2.2.  Mass spectra of P_1030. 
  
m/z 1031.5772 
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Fig. 2.3.  Mass spectra of P_1028. 
  
m/z 1029.5615 
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Fig. 2.4.  Mass spectra of P_1026. 
  
m/z 1027.5459 
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Fig. 2.5.  Mass spectra of P_1014. 
  
m/z 1015.5459 
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Fig. 2.6.  Mass spectra of P_1008. 
  
m/z 1009.5353 
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Fig. 2.7.  Mass spectra of P_964. 
  
m/z 965.5455 
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Fig. 2.8.  Mass spectra of P_810. 
  
m/z 811.3945 
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Fig. 2.9.  Mass spectra of P_794. 
  
m/z 795.3985 
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Fig. 2.10.  Mass spectra of P_782. 
  
m/z 783.3995 
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Fig. 2.11.  Mass spectra of P_758. 
  
m/z 759.3995 
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Fig. 2.12.  Mass spectra of P_754. 
  
m/z 745.3839 
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Fig. 2.13.  Mass spectra of P_742. 
  
m/z 743.4046 
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Fig. 2.14.  Mass spectra of P_705. 
  
m/z 705.3050 
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Fig. 2.15.  Mass spectra of P_674. 
  
m/z 675.3308 
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Fig. 2.16.  Mass spectra of P_361. 
m/z 362.1962 
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Fig. 2.17.  Mass spectra of P_361. 
m/z 346.2013 
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2.3.1 Hydroxylation at the Adda diene 
Fig. 2.18 gives Scheme 1, which involves the hydroxylation of MC-LR, followed 
by the removal of the Adda amino acid, and finally the breakage of the heptapeptide 
ring.  In this proposed pathway, the Adda chain or the benzene ring is the most 
vulnerable attack site.  The products with a MW of 1044.5492 correspond to the 
simultaneous mono-hydroxylation of MC-LR at the benzene ring and dihydroxylation at 
the Adda moiety. A MW of 1028.5542 relates to isomers of a 1,2 or 2,4 hydroxyl 
addition to the Adda diene, and the product with a MW of 1026.6386 is obtained from 
the di-hydroxylation of the benzene ring. In Scheme 1, the subsequent oxidation of 
hydroxylated intermediates led to the removal of the Adda chain. Products with a MW of 
794.3923, 782.3923, and 810.3872 correspond to the intact heptapeptide ring with either 
an O, OH or COOH, respectively. The final products of this pathway yielded from the 
further cleavage of the heptapeptide cyclic structure have MWs of 674.3235 and 
704.2977. 
Both FeV and FeIV species showed the mono-hydroxylation of the benzene ring 
of the MC-LR (P_1044 in Scheme 1). This is the consistent with our previous finding 
that these intermediate reduced iron species are produced during the oxidation of MC-
LR by FeVI species in order to hydroxylate the benzene ring of the MC-LR (Jiang, et al., 
2014).  In the biological systems, ferryl (Fe(IV) and perferryl (Fe(V)) species have also 
shown hydroxylation of the benzene ring (Cho, et al., 2016; Nam, et al., 2014; Ray, et 
al., 2015; Sharma and Zboril, 2015). The reactivities of FeV and FeIV species with 
compounds are orders of magnitude higher than the FeVI species (Sharma, 2002a; 
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Sharma, et al., 2008; Sharma, 2013); therefore, the observation of a mono-hydroxylation 
derivative of MC-LR by all the ferrate species is reasonable. Significantly, di-
hydroxylation at the benzene ring was only observed in the FeVI(L) experiments, 
evidenced by the absence of a product with a MW of  1026.6386 in FeV and FeIV 
experiments regardless of concentration tested (Scheme 1). FeV and FeIV species, which 
are highly unstable, were also simultaneously self-decomposed (Bielski, et al., 1994; 
Menton and Bielski, 1990; Sharma, 2011) and were not available to result in further 
hydroxylation of the aromatic ring. 
In the oxidation of MC-LR by FeV species, the heptapeptide ring with OH was 
not stable, demonstrated by the absence of a product with a MW of 782.3923 (Scheme 
1). Nevertheless, a more oxidized product (MW 810.3872) was present at all 
concentrations of FeV species (Scheme 1). At all levels of FeVI species (L, M, and H), the 
oxidized product with a MW of 674.3235 was not observed.  This indicates that this 
product was either not persistent or that FeVI oxidized the intermediate directly into a 
transformation product having a nitro group (P_704 in Scheme 1). This is in agreement 
with products observed in the oxidation of amines by ferrate species (Carr, 2008; 
Johnson and Hornstein, 2003; Johnson, et al., 2008). Experiments with FeIV species 
showed cleavage of the Adda diene, but no further breakage of the heptapeptide cyclic 
ring was seen. The simultaneous self-degradation of FeIV species may be occurring 
(Menton and Bielski, 1990; Sharma, 2011), and no significant amount of FeIV was 
available to carry out additional oxidation. 
56 
 
Fig. 2.18. Scheme 1 - hydroxylation at the Adda diene, indicating products observed 
under high (H), medium (M), and low (L) concentrations of FeVI, FeV and FeIV. 
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2.3.2 Elimination of the methoxy group of the Adda diene 
Fig. 2.19 shows the proposed Scheme 2 that shows the attack of ferrate species at 
the methoxyl at the Adda moiety, followed by hydrolysis of the intermediate products. 
The structure assigned to a compound with a MW of 1008.5280 is of a formic acid ester 
MC-LR (Antoniou, et al., 2008; Su, et al., 2013). Further oxidations in this pathway of 
Scheme 2 resulted in the complete removal of the methoxy group (MW of 964.5382). 
Breakage of the heptapeptide ring was also shown with the presence of a MW of 
345.1940. FeVI species have the capability to oxidize peptide bonds (Noorhasan, et al., 
2010), and the proposed product with a low MW is well justified. A combination of 
breakage of the heptapeptide ring and monohydroxylation of the benzene ring yield a 
product with a MW of 361.1889. This step is similar to the reported pathway in the 
photocatalytic transformation of MC-LR using TiO2 (Antoniou, et al., 2008; Su, et al., 
2013). 
At the medium concentration of FeIV, a compound with MW 964.5382 was 
found, which was not seen at other levels of FeIV species (Scheme 2). It appears that this 
compound was further degraded by the addition of FeIV because it is only present at a 
medium concentration of FeIV (i.e., FeIV(M)). Another significant observation of Scheme 
2 was the absence of the intermediate of MC-LR without the methoxy group (i.e., 
P_1008.5280) at every concentration of FeVI. However, this compound was present 
during the oxidation of MC-LR by FeIV and FeV (Scheme 2). The formation of the MWs 
of 345.1940 and 361.1889 at even a low concentration of FeVI (FeVI(L)) implies that the 
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product compound with MW 1008.5280 could be oxidized by FeVI species step-wise to 
low MW OPs.  FeV and FeIV species also yielded these low MW OPs (Scheme 2). 
 
Fig. 2.19. Scheme 2 - elimination of the methoxy group of the Adda diene, indicating 
products observed under high (H), medium (M), and low (L) concentrations of FeVI, FeV 
and FeIV. 
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2.3.3 Hydroxylation at the diene bond of the Mdha  
Scheme 3 (Fig. 2.20) involved the hydroxylation of MCLR, followed by 
breakage of the cyclic structure, and finally the removal of the Adda amino acid.  In this 
pathway, the peaks with a MW of 1028.5542 were related to hydroxylation at the Mdha.  
Multiple products of MW of 1044.5492 correspond to simultaneous mono-hydroxylation 
at the benzene ring and dihydroxylation at the Mdha. The double bond of the Mdha was 
an initiation site for the oxidation of the heptapeptide ring. In Scheme 3, we propose a 
cleavage at this site to form a MW of 1014.5386. Compounds with MWs of 1044.5492 
and 1014.5386 undergo separation of the Adda chain and Mdha from the peptides to 
form a MW of 742.3974. Further oxidation resulted in the observed carboxylic acid with 
a MW of 758.3923. The amino group in the products of MW 758.3923 and 742.3974 
could oxidize into a nitro group (see Scheme 3). The final oxidized product has a MW of 
744.3766. FeIV species did not participate to give this transformation product. 
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Fig. 2.20. Scheme 3 - hydroxylation at the diene bond of the Mdha, indicating products observed under high (H), medium 
(M), and low (L) concentrations of FeVI, FeV and FeIV. 
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3. TRANSFORMATION PRODUCTS OF MICROCYSTIN-LR DEGRADATION 
BY FERRATE(VI), FERRATE(V), AND FERRATE((IV): INFLUENCE OF pH 
3.1. Introduction 
Increasing occurrence of cyanobacteria blooms (blue green algae) in eutrophied 
water is of pronounced concern worldwide (Pick, 2016; Sandrini, et al., 2016). Growth 
of cyanobacteria releases cyanotoxins of which microcystins (MCs) are among the 
priority hazards to animal and public health (Liyanage, et al., 2016). MCs are a group of 
cyclic heptapeptides, produced by Microcystis aeruginosa (Wood, 2016). MCs generate 
toxins which are damaging to the liver and the nervous system (Meneely and Elliott, 
2013). Contamination by MCs has resulted in human poisoning (Weirich and Miller, 
2014). Examples include the high prevalence of liver cancer in areas of the Chinese 
population which are dependent on surface drinking water (Hernández, et al., 2009; 
Tian, et al., 2013). Hepatic injury due to the use of MCs-contaminated water to treat 
more than 50 dialysis patients resulted in their deaths (Pouria, et al., 1998). Among the 
various identified MCs, microcystin-LR (MC-LR) is the common species detected in 
surface water (Hilborn, et al., 2007; Merel, et al., 2013). The structure of MC-LR 
consists of D-alanine, γ-linked-D-glutamic acid, D-erythro-β-methylaspartic acid 
(Adda), N-methyl dehydroalanine, and two variable amino acids, leucine (L) and 
arginine (R). MC-LR is highly stable for months or years in natural waters (Sharma, et 
al., 2012). Significantly, MC-LR can also persist in harsh environments, such as low pH 
and high temperature (Adamovsky, et al., 2015). The Adda group in MC-LR is one of 
the key constituents mainly responsible for its toxicity. The maximum level of 1.0 μg/L 
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of MC-LR in drinking water has been adopted as a guideline by the World Health 
Organization (WHO) (World Health Organization, 1997). Many investigations have 
been performed to seek efficient methods for detoxifying water contaminated with MC-
LR (Merel, et al., 2013; Sharma, et al., 2012, 2017). 
Physical adsorption/separation, chemical oxidation, and advanced oxidation 
processes (AOPs) have been studied to remove MC-LR in water (de la Cruz, et al., 2011; 
Fagan, et al., 2016; Lee and Walker, 2008; Sharma, et al., 2010; Sharma, et al., 2012; 
Svrcek and Smith, 2004; Teixeira and Rosa, 2005). These different treatment methods 
had mixed results. Physical methods potentially remove MC-LR in water, but it still 
remains in the environment. Chlorination contributes chlorinated derivatives of MC-LR 
and disinfection byproducts (DBPs) to the treated water (Zhang, et al., 2016). 
Applications of highly reactive hydroxyl (•OH) and sulfate (SO4
•-) radicals in AOPs 
(Antoniou, et al., 2010; He, et al., 2015; Sharma, et al., 2012) have shown efficient 
removal of MC-LR in water. In our recent studies, we have established the use of an iron 
oxide compound, ferrate(VI) (FeVIO4
2-, FeVI), in detoxifying MC-LR in natural water 
(Jiang, et al., 2014). The half-life(t1/2) of the oxidation by Fe(VI) was 155 s for a dose of 
FeVIO4
2- as 2.2 mg L-1 at pH 7.0. Products from the oxidation of MC-LR were seen 
mainly from the hydroxylation of the double bond of the methyldehydroalanine (Mdha), 
the diene functionality, and the aromatic ring (Jiang, et al., 2014). The understanding of 
the hydroxylation of the aromatic moiety of the MC-LR by FeVI was explored by 
studying independently the formation of aromatic hydroxylated products obtained during 
oxidation carried out by the intermediate high-valent iron species, FeV (FeO4
3-) and FeIV 
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(FeO4
4-) (Chen, et al., 2017). In the literature, only a handful studies have been 
conducted on the oxidation of compounds by FeVI, FeV, and FeIV species (Kralchevska, 
et al., 2016; Machalová Šišková, et al., 2016; Sharma, et al., 2008, 2015, 2016a). 
Furthermore, almost no research has been carried out on determining the influence of pH 
on the mechanism of the reactions of these high-valent iron species with compounds. 
In the present paper, we focus on studying the effect of pH on the formation of 
oxidized products (OPs) during the oxidation of MC-LR by FeVI, FeV, and FeIV species 
(Jiang, et al., 2014). The reasoning behind this investigation was two-fold: (i) the 
addition of solid FeVI species (e.g. potassium ferrate(VI), K2FeO4) to treat water with no 
buffer capacity may result in an increase of pH (2FeVIO4
2- + 5H2O → 2Fe3+ + 3/2O2 + 
10OH-), and it is imperative to learn what kind of OPs are formed under basic 
conditions. (ii) it is important to elucidate the effect of pH over the entire pH range from 
acidic to basic on the degradation pathways of the oxidation of MC-LR by FeVI, and 
subsequently by FeV, and FeIV species in water. 
3.2.  Experimental methods 
3.2.1. Product studies 
In this set of experiments, solids of salts of FeVI (K2FeO4), Fe
V (K3FeO4), and 
FeIV (Na4FeO4) were added into a buffered solution containing 5.00 µM MC-LR at pH 
4.0, 7.0, and 9.0. Mixed solutions of FeVI and MC-LR were allowed to react until the 
characteristics color of FeVI disappeared. In the case of FeV/FeIV and MC-LR mixed 
solutions, the reactions were stopped immediately (<10 s) by adding excess 
hydroxylamine. Hydroxylamine as a quenching agent can stop any reactions that might 
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occur from the products of self-decomposition of FeV and FeIV with MC-LR (Machalová 
Šišková, et al., 2016). In addition, the salts of FeV have impurities of FeVI, which could 
interfere with the target reaction between FeV and MC-LR. Moreover, the self-
decomposition of FeIV instantaneously forms FeVI, and hence an immediate addition of 
hydroxylamine could stop any possible reaction between FeVI and MC-LR. This 
approach allowed the study of only the reaction between FeIV and MC-LR.  Products of 
reactions of FeVI, FeV, and FeIV with MC-LR were analyzed using liquid chromatography 
high resolution mass spectrometry.  Details of the technique are provided in Chapter 2. 
Information on the products is available in Table 2.1. 
3.3. Results and discussion 
3.3.1. Influence of pH on Scheme 1: Hydroxylation of the Adda diene 
 In this Scheme 1, the products with MWs of 1028.5442 (P_1028), 1044.5492 
(P_1044), 1026.6386 (P_1026), 794.3923 (P_794), 782.3923 (P_782), and 810.3872 
(P_810) were formed during the oxidation of MC-LR by FeVI, FeV, and FeIV at different 
concentrations of oxidants and pH (Fig. 3.1). The di-hydroxylation of the benzene ring 
in MC-LR gave a product, P_1026. A product, P_1028 was formed by the 1,2 or 2,4 
hydroxy addition to Adda diene of MC-LR. The subsequent aromatic hydroxylation of 
P_1028 yielded a product, P_1044. The elimination of the Adda chain from either 
P_1026 or P_1044 gave P_794 with an intact heptapeptide ring containing the C=O 
moiety. Further oxidation of P_794 by ferrates yielded a product, P_782. The product, 
P_810 was formed from the oxidation of –C=O in P_794 to a –COOH group (Scheme 1). 
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Fig. 3.1. Scheme 1 - hydroxylation at the Adda diene by FeVI, FeV and FeIV. 
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 The pH dependence of the products shown in Scheme 1 is presented in Figs. 3.2-
3.6. The formation of P_1026 by the oxidation of MC-LR by FeVI, FeV, and FeIV 
generally occurred predominately at an acidic pH (Fig. 3.2). In neutral media, this 
product was observed only in the FeVI oxidation of MC-LR. However, a basic pH was 
not favorable to the formation of P_1026 by FeVI.  Both FeV and FeIV were able to 
oxidize MC-LR to P_1026 in a basic medium (Fig. 3.2). This suggests that aromatic 
hydroxylation of MC-LR by FeV and FeIV could occur in either acidic or basic pH media. 
 Hydroxylation of the Adda diene by FeVI, FeV, and FeIV was facilitated under 
acidic conditions (Figs. 3.3 and 3.4). All ferrate species could convert MC-LR to the 
product, P_1044, at pH 4.0 (Fig. 3.3). The intermediate product, P_1028, for the 
formation of P_1044 could also be seen at pH 4.0 (Fig. 3.4). Compared to pH 4.0, 
intensities of the P_1044 and P_1028 decreased significantly at pH 7.0 (Figs. 3.3 and 
3.4). This indicates that the increase in pH from pH 4.0 to 7.0 produced a less favorable 
environment for the hydroxylation of the Adda diene of the MC-LR by ferrates. 
Interestingly, a further increase in pH showed the formation of P_1044 in basic pH 9.0. 
Almost no peak intensity or small intensity of the peak for product P_1028 was seen at 
pH 9.0. The product, P_1028, was the intermediate product of the hydroxylation of the 
diene of MC-LR before giving the product P_1044 (Fig. 3.3). 
 As shown in Fig. 3.5, the elimination of the Adda chain from the products, 
P_1026 and P_1044, to give a product, P_794, by FeVI, FeV, and FeIV could be seen over 
almost the entire pH range. However, intensities of the peak of this product suggest that 
an acidic environment was more favorable than neutral and basic conditions. The 
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oxidation of P_794 to P_810 by all ferrates usually had a similar trend with the pH as 
well (Fig. 3.6). A comparison of peak intensities between neutral pH and basic pH 
suggests that the formation of –COOH in the product, P_810, from the product, P_794, 
was facilitated by basic conditions (Fig. 3.6). 
 Fig. 3.7 presents the pH dependence of the formation of P_782 via the 
elimination of the Adda chain from P_1044.  This step of elimination in Scheme 1 was 
observed mostly at pH 4.0 (Fig. 3.7). This pH dependence for the formation of P_782 
from P_1044 was seen for all oxidants (FeVI, FeV, and FeIV). At pH 7.0 and 9.0, FeV and 
FeIV did not yield the product, P_782. The formation of P_782 was shown in the 
oxidation of P_1044 by FeVI. No significant amount of P_794 at pH 9.0 was observed.  
Overall, the results of Fig. 3.7 indicate that the elimination of the Adda chain from the 
product, P_1044 was more pronounced in an acidic pH than in either a neutral or a basic 
pH. 
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Fig. 3.2.  Intensity of P_1026 during the oxidation of MC-LR by FeVI, FeV, and FeIV at 
different molar ratios of ferrates to MC-LR ([Ferrates] = 200-800 µM and [MC-LR] = 5 
µM). 
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Fig. 3.3. Intensity of P_1028 during the oxidation of MC-LR by FeVI, FeV, and FeIV at 
different molar ratios of ferrates to MC-LR ([Ferrates] = 200-800 µM and [MC-LR] = 5 
µM). 
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Fig. 3.4. Intensity of P_1044 during the oxidation of MC-LR by FeVI, FeV, and FeIV at 
different molar ratios of ferrates to MC-LR ([Ferrates] = 200-800 µM and [MC-LR] = 5 
µM). 
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Fig. 3.5. Intensity of P_794 during the oxidation of MC-LR by FeVI, FeV, and FeIV at 
different molar ratios of ferrates to MC-LR ([Ferrates] = 200-800 µM and [MC-LR] = 5 
µM). 
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Fig. 3.6. Intensity of P_782 during the oxidation of MC-LR by FeVI, FeV, and FeIV at 
different molar ratios of ferrates to MC-LR ([Ferrates] = 200-800 µM and [MC-LR] = 5 
µM). 
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3.3.2. Influence of pH on Scheme 2: Elimination of the methoxy group of the Adda 
diene 
Scheme 2 involves three products from the oxidation of the methoxyl group of 
the Adda moiety (Fig. 3.8). Initially a compound with MW of 1008.5280 (P_1008) is 
formed, which is a formic ester of MC-LR (Antoniou, et al., 2008; Su, et al., 2013). 
Further oxidation of this compound resulted in two products with MWs of 345.1940 
(P_345) and 361.1889 (P_361).  Formation of a P_345 resulted from the breakage of the 
heptapeptide ring of P_1008. The aromatic hydroxylation of P_345 yielded P_361. 
The influence of pH on the three products, P_1008, P_345, and P_361, from the 
oxidation of MC-LR by FeVI, FeV, and FeIV at three molar ratios of ferrates to MC-LR is 
presented in Figs. 3.9-3.11. The formation of P_1008 was not seen in the oxidation of 
MC-LR by FeVI at any of the studied pHs (Fig. 3.9). However, P_1008 was observed in 
the oxidation of MC-LR by FeV and FeIV. The formation of P_1008 was seen at all pHs.  
The oxidation of MC-LR by FeV had higher intensity under acidic pH than under either 
neutral or basic pH (Fig. 3.9). No such pH dependence was seen in the formation of 
P_1008 by the oxidation of MC-LR by FeIV (Fig. 3.9). Significantly, when FeIV was the 
oxidant, the formation of P_1008 was more prevalent under a basic condition at the 
lowest molar ratios of oxidant to MC-LR (Fig. 3.9).  
 P_345 and P_361 were seen in the oxidation of all three ferrate species (Figs. 
3.10 and 3.11). This suggests that the formation of P_345 occurred without going 
through the P_1008 as was the case with oxidation of MC-LR by FeV and FeIV (see Fig. 
3.10). Importantly, both P_345 and P_361 were observed over the entire pH range from 
74 
 
the acidic to basic pH range (Figs. 3.10 and 3.11). Also, similar intensities of these 
products were obtained at all concentrations of FeVI or FeV or FeIV. This indicates 
ferrates species not only reacted with MC-LR but were also consumed by self-
decomposition reactions in water. 
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Fig. 3.7.  Intensity of P_810 during the oxidation of MC-LR by FeVI, FeV, and FeIV at 
different molar ratios of ferrates to MC-LR ([Ferrates] = 200-800 µM and [MC-LR] = 5 
µM). 
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Fig. 3.8. Scheme 2 - elimination of the methoxy group of the Adda diene by FeVI, FeV 
and FeIV.
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Fig. 3.9.  Intensity of P_1008 during the oxidation of MC-LR by FeVI, FeV, and FeIV at 
different molar ratios of ferrates to MC-LR ([Ferrates] = 200-800 µM and [MC-LR] = 5 
µM). 
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Fig. 3.10. Intensity of P_345 during the oxidation of MC-LR by FeVI, FeV, and FeIV at 
different molar ratios of ferrates to MC-LR ([Ferrates] = 200-800 µM and [MC-LR] = 5 
µM). 
  
78 
 
Fe
VI
pH
4 7 9
In
te
n
is
ty
0
1000
2000
3000
4000
5000
6000
40:1
80:1
160:1
P_361
Fe
V
pH
4 7 9
In
te
n
s
it
y
0
1000
2000
3000
4000
5000
40:1
80:1
160:1
Fe
IV
pH
4 7 9
In
te
n
s
it
y
0
1000
2000
3000
4000
5000
40:1
80:1
160:1
 
Fig. 3.11. Intensity of P_361 during the oxidation of MC-LR by FeVI, FeV, and FeIV at 
different molar ratios of ferrates to MC-LR ([Ferrates] = 200-800 µM and [MC-LR] = 5 
µM). 
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3.3.3.  Influence of pH on hydroxylation at the diene bond of the Mdha 
Fig. 3.12 shows the hydroxylation at the Mdha of MC-LR, which resulted in a 
product with a MW of 1028.5542 (P_1028). The monohydroxylation of this product at 
the benzene ring gave a product with a MW of 1044.5492 (P_1044). The cleavage of the 
double bond of the Mdha by the oxidation of the heptapeptide ring yielded a product 
with a MW of 1014.536 (P_1014). As shown in Scheme 3 of Fig. 3.12, the products, 
P_1044 and P_1014, formed a product with a MW of 742.3974 (P_742) via separation 
of the Adda chain and Mdha, respectively. Ferrates species further oxidized the P_742 
and produced a compound with a carboxylic acid group with a MW of 758.3923 
(P_758). The nitro group containing product was generated from P-758 that had a MW 
of 744.3766 (P_744) (Fig. 3.12). 
The pH dependence of the products of the Scheme 3 is given in Figs. 3.13-3.18. 
The formation of P_1044 through P_1028 by FeVI, FeV, and FeIV was preferable in an 
acidic medium compared to neutral and basic media (Fig. 3.14). In the case of the 
product P_1014, FeVI was able to form it only at a neutral pH (Fig. 3.14). In comparison, 
FeV and FeIV usually produced P_1014 at almost all concentrations over the entire pH 
range from 4.0 – 9.0 (Fig. 3.15). Both P_1044 and P_1014 resulted in P_742, which was 
mostly seen during the oxidation of MC-LR by FeVI at different pHs (Fig. 3.16). Since 
P_1014 resulting from oxidation by FeVI occurred mainly at a neutral pH, the formation 
of P_742 therefore predominantly resulted from P_1044 at acid and basic pHs.  The 
product P_758 was formed mainly by FeVI. All species of ferrates (i.e. FeVI, FeV, and 
FeIV) gave the product, P_744, while the product P_758 appears to be an intermediate 
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during the oxidation of P_742 to P_744 by FeV and FeIV (see Figs. 3.16-3.18). All 
species of ferrates gave P_744 at pH 4.0.  At pH 7.0, FeVI and FeV generated P_744, but 
FeIV was not able to produce this product (Fig. 3.18). In a basic medium, FeVI could not 
result in P_758 and P_744, and the final product of Scheme 3 for the oxidation of MC-
LR by FeVI was P_742. The final product of the oxidation of MC-LR by FeV and FeIV in 
Scheme 3 (Fig. 3.12) under the basic medium was P_744. 
 
Fig. 3.12. Scheme 3 - hydroxylation at the diene bond of the Mdha by FeVI, FeV and 
FeIV. 
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Fig. 3.13.  Intensity of P_1028 during the oxidation of MC-LR by FeVI, FeV, and FeIV at 
different molar ratios of ferrates to MC-LR ([Ferrates] = 200-800 µM and [MC-LR] = 5 
µM). 
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Fig. 3.14.  Intensity of P_1044 during the oxidation of MC-LR by FeVI, FeV, and FeIV at 
different molar ratios of ferrates to MC-LR ([Ferrates] = 200-800 µM and [MC-LR] = 5 
µM). 
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Fig. 3.15.  Intensity of P_1014 during the oxidation of MC-LR by FeVI, FeV, and FeIV at 
different molar ratios of ferrates to MC-LR ([Ferrates] = 200-800 µM and [MC-LR] = 5 
µM). 
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Fig. 3.16.  Intensity of P_742 during the oxidation of MC-LR by FeVI, FeV, and FeIV at 
different molar ratios of ferrates to MC-LR ([Ferrates] = 200-800 µM and [MC-LR] = 5 
µM). 
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Fig. 3.17. Intensity of P_758 during the oxidation of MC-LR by FeVI, FeV, and FeIV at 
different molar ratios of ferrates to MC-LR ([Ferrates] = 200-800 µM and [MC-LR] = 5 
µM). 
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Fig. 3.18. Intensity of P_744 during the oxidation of MC-LR by FeVI, FeV, and FeIV at 
different molar ratios of ferrates to MC-LR ([Ferrates] = 200-800 µM and [MC-LR] = 5 
µM). 
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4. OXIDATION OF SULFADIAZINE BY FERRATE(VI): KINETICS AND 
OXIDIZED PRODUCTS 
4.1. Introduction 
Pharmaceuticals in water and wastewater have emerged as one of the most 
important public and ecological health concerns (Cizmas, et al., 2015; Carvalho and 
Santos, 2016).  The consumption of pharmaceuticals has increased because of an 
increase in the world population and of the aging population in industrialized countries 
(aus der Beek, et al., 2016; Cizmas, et al., 2015).  An overuse of pharmaceuticals has 
caused growing concern because their release into the environment presents potential 
risks to human health and ecosystems (Carraro, et al., 2016; Hu, et al., 2017). Generally, 
pharmaceuticals are only slightly degraded or even unchanged as the parent compounds 
are released into wastewater treatment plants and subsequently enter into the aquatic 
environment (Cizmas, et al., 2015; Hu, et al., 2017). In addition, the direct input by the 
use of drugs in aquaculture facilities and the indirect input through manure application 
during agricultural activities as well as release from manufacturing sites, hospitals, and 
nursing homes have greatly contributed to the widespread occurrence of pharmaceuticals 
in natural waters (Bu et al., 2013; Carraro, et al., 2016). Recent studies also indicated 
that many pharmaceuticals are persistent or pseudo-persistent in the environment, which 
ultimately lead to their bioaccumulation in aquatic organisms of different trophic levels.  
This has resulted in the exertion of adverse effects on non-target organisms (Bu, et al., 
2013; Sharma, et al., 2016b). 
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Antibiotics are among various pharmaceuticals that have received a great deal of 
attention in the last two decades (Carvalho and Santos, 2016; Kim, et al., 2013; Meng, et 
al., 2016). The occurrence of antibiotics in the environment has resulted in the growth of 
antibiotic resistant bacteria (ARBs) and antibiotic resistant genes (ARGs) (Ben, et al., 
2017; Sharma, et al., 2016b). According to the World Health Organization, ARBs are the 
one of the most important global health problems of this century (World Health 
Organization, 2014). Sulfonamides are among antibiotics which are widely used in 
veterinary and human medicines (Chen, et al., 2015; Hoff, et al., 2016). They may enter 
into the environment through leaching from manure and effluents of aquaculture ponds 
and wastewater. The present paper focuses on sulfadiazine (SDZ, 4-amino-N-(2-
pyrimidinyl) benzenesulfonamide), which is extensively used as veterinary medicine and 
is considered as a high priority sulfonamide because of its great potential to enter into 
the environment (Feng, et al., 2016c). Notably, Bu et al. (2013) recently reviewed the 
existing studies and occurrence data of SDZ in China, and reported its concentrations 
ranging from ND (not detected) to 505 ng/L in surface waters. 
  Many studies have been forthcoming to effectively treat antibiotics in water 
before their release into the environment. The treatment techniques include biological 
treatment, adsorption, membrane processes, chlorination, electrochemical means, and 
advanced oxidation technology (Barbosa, et al., 2016; Ganiyu, et al., 2015; Haddad, et 
al., 2015; Moreira, et al., 2016; Oturan and Aaron, 2014; Polesel, et al., 2016; Pérez, et 
al., 2017; Verlicchi, et al., 2015; Yu, et al., 2016). Of these approaches, oxidative 
technologies are promising because the treatment also eliminates antibiotic activities of 
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the parent compound. In the current paper, we explore the use of an iron-based oxidant, 
ferrate(VI) (FeVIO4
2-, FeVI), to oxidize SDZ in water.  FeVI has been investigated as a 
green chemical to transform pharmaceuticals including sulfonamides (Jiang, 2014; 
Karlesa, et al., 2014; Kralchevska, et al., 2016; Machalová Šišková, et al., 2016; Sharma, 
et al., 2008, 2016a; Yang, et al., 2016; Zhou and Jiang, 2015b). Most of the studies of 
sulfonamides were performed on sulfamethoxazole (SMX, 4-amino-N-(5-
methylisoxazole-3-yl)-benzenesulfonamide), but no detailed studies were conducted on 
the oxidation of SDZ by FeVI. Products obtained were from the attacks on the aniline and 
isoxazole moieties as well as the breakage of the S-N bond (Kim, et al., 2015; Sharma, et 
al., 2015; Sharma, et al., 2006a; Zhou and Jiang, 2015b). Particularly, a pathway 
involving the extrusion of SO2 has not been shown in the oxidation of sulfonamides by 
FeVI. In this paper, we demonstrate for the first time the products identified after SO2 
extrusion from the transformation of SDZ by FeVI. 
 Objectives of the paper are: (i) to study the kinetics of the reaction between FeVI 
and SDZ as a function of pH and to determine the species-specific rate constants, and (ii) 
to identify the transformation products of the oxidation of SDZ by FeVI by a liquid 
chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) technique. 
4.2.  Materials and methods 
4.2.1 Chemicals and reagents 
Sulfadiazine, sodium dihydrogen phosphate, and sodium borate phosphate were 
obtained either from Fisher-Scientific (Austin, TX, USA) or Sigma-Aldrich (St. Louis, 
MO, USA). The purity of the chemicals was greater than 97%, and they were used 
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without further purification. Organic solvents of methanol and acetonitrile used in the 
high-performance liquid chromatography (HPLC) were obtained from Fisher-Scientific.  
Solid potassium ferrate (K2FeO4) of ~98% purity was synthesized by the wet chemical 
technique (Luo, et al., 2011). Solutions of FeVI were prepared by dissolving solid 
K2FeO4 in 1 mM Na2B4O7•10H2O/5 mM Na2HPO4 at pH 9.0. In this solution, Fe(VI) is 
sufficiently stable to perform experiments. Absorbance of FeVI solutions was conducted 
at a wavelength of 510 nm using a UV-Visible spectrophotometer. An extinction 
coefficient, ε510nm = 1150 M-1 cm-1, was used to determine the concentration of FeVI. All 
solutions were made in water that was obtained from a purification system (18 MΩ cm 
Milli-Q Millipore, Waters Alliance, Milford, MA, USA).  In kinetic experiments, the 
solution of sulfadiazine was prepared by dissolving the solid compounds in a 10 mM 
Na2HPO4 buffer-acetone (85:15) solution. The pH of the solution was adjusted by 
adding either NaOH or phosphoric acid. In the product analysis of the oxidation of SDZ 
by FeVI, the solution of SDZ was in the buffer solution at pH 9.0. 
4.2.2. Stopped-flow experiments 
Experiments were conducted under pseudo-first-order conditions to perform the 
kinetics of the reactions between FeVI and SDZ. Under this condition, the concentrations 
of SDZ was higher than the Fe(VI) concentration. The kinetic measurement was 
performed using a stopped-flow spectrophotometer (SX-20 MV, Applied Photophysics, 
Surrey, UK). Kinetic traces were monitored at a wavelength of 510 nm. Results from the 
stopped-flow spectrophotometer were analyzed using the nonlinear least-square 
algorithm of the SX-20 MV Global Software (Applied Photophysics, Surrey, UK). Six 
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replicate runs were made to determine averaged rate constants. The pseudo-first-order 
rate constants were evaluated by subtracting the observed rate constants for the reaction 
from the rate constants of the control (i.e., Fe(VI) decay without SDZ) at each studied 
pH). 
4.2.3  Oxidized product experiments 
The oxidized products (OPs) of SDZ by Fe(VI) were determined using solid 
phase extraction-liquid chromatograph mass spectrometry (SPE-LC-MS) (Feng, et al., 
2016a). Chromatographic separation was carried out by a Thermo BDS Hypersil C18 
column (2.1 mm × 100 mm, particle size 2.4 μm) (Thermo Fisher Scientific, Waltham, 
MA, USA) at a flow rate of 200 μL/min and 30 °C. The mobile phase consisted of 0.3% 
formic acid in water (A) and methanol (B). The linear gradient started with 90% A, 
which was held for 2 min, decreased to 10% in 1 min, maintained for 23 min, returned to 
the initial condition in 1 min, and followed by an 8 min equilibration. The injection 
volume of each sample was 10 μL, and the total elution time was 35 min. 
MS detection was performed using an Agilent 1260 Infinity HPLC coupled with 
a hybrid quadrupole time-of-flight mass spectrometer (LC-MS-Triple TOF 5600, AB 
Sciex, Foster City, CA) operating in positive ion mode using an electrospray interface 
(ESI) source. The mass range of the TOF MS was m/z 70 to 700. The other experimental 
parameters were set as follows: nebulizer gas (gas 1), 55 psi; heater gas (gas 2), 55 psi; 
curtain gas, 35 psi; temperature, 550 °C; ionspray voltage floating, 5500 V; declustering 
potential, 80 V; and collision energy, 10 V. All gases used were nitrogen. Following the 
MS analysis, the protonated molecular ions [M + H]+ of certain OPs were chosen as the 
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parent ions to yield the characteristic MS/MS fragments using the product ion mode. 
Additionally, the Q-TOF MS was automatically calibrated using an APCI positive 
calibration solution delivered via a calibration delivery system (AB Sciex, Concord, ON, 
Canada). The LC-MS data were acquired by Analyst TF software (Version 1.6, AB 
Sciex, Concord, ON, Canada) and processed by PeakView software (Version 1.2, AB 
Sciex, Concord, ON, Canada). 
4.3.  Results and discussion 
4.3.1.  Kinetics 
 Initially, the reaction between FeVI and SDZ was studied at pH 8.94 by observing 
the decay of FeVI as a function of time under pseudo-order conditions in which SDZ was 
in excess. As shown in Fig. 4.1, the decrease in the absorbance of FeVI with time follows 
nicely the exponential decay. This suggests that the rate of the reaction is first-order with 
respect to the concentration of FeVI. The kinetic traces of FeVI were repeated five more 
times, and the first-order rate constant (k1) at pH 9.0 was obtained as (3.78±0.34)×10
1 M-
1s-1. 
 Next, similar experiments were conducted at pH 7.00 by varying the 
concentrations of SDZ.  Decay curves of FeVI with time at different levels of SDZ were 
evaluated for values of k1. Fig. 4.2 shows the plot of k1 at various concentrations of SDZ. 
The linearity of the plot indicates that the rate of the reaction between FeVI and SDZ was 
first-order with respect to the concentrations of SDZ, and it can be expressed as 
 -d[Fe(VI)]/dt = k[Fe(VI)][SDZ]      (4.1) 
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where k is the second-order rate constant of the reaction.  The value of k at pH 7.00 was 
(8.44±0.24)×102 M-1s-1. This increase in value of k at pH 7.0 from the value at pH 9.0 
has been observed in the reactions of FeVI with several inorganic and organic compounds 
(Karlesa, et al., 2014; Kralchevska, et al., 2016; Lee and von Gunten, 2012; Sharma, et 
al., 2015). 
 The value of k at pH 7.0 can be used to learn the half-life (t1/2) of the elimination 
of SDZ by FeVI. A calculated value of t1/2 was determined as 66 s if the concentration of 
FeVI is in excess over SDZ at a dose of [Fe] = 1 mg L-1 or [FeO4
2-] = 2.2 mg L-1. Because 
the values of k are pH dependent, the half-lives for the elimination of SDZ by Fe(VI) 
would also vary with pH. Additionally, variation in the dose of FeVI would also change 
the t1/2 to remove SDZ by Fe
VI. 
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Fig. 4.1.  Kinetic traces of the decay of FeVI at 510 nm in the reaction between FeVI and 
SDZ at pH 9.0 and at 25 oC. ([FeVI] = 50 µM and [SDZ] = 500 µM) 
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Fig. 4.2. Pseudo first-order rate constant (k1, s
-1) for the oxidation of SDZ by FeVI at pH 
9.0 and at 25 oC. ([FeVI] = 50 µM) 
Finally, values of k at other pHs were determined in the pH range from pH 4.5 to 
10.0. Results shown in Fig. 4.3 give the dependence of k on the pH. In the pH range 
from 4.0 to 7.0, rates slowly decreased with an increase in pH. However, a sharp 
decrease in the rate constants was observed when the pH increased from 7.0 to 10.0. 
Similar trends in the values of k with pH in the acidic to basic pH range were observed 
in the oxidation of other sulfonamides (Kim, et al., 2015; Lee, et al., 2009; Sharma, et 
al., 2006a; Sharma, et al., 2006b). 
The variation in the values of k with pH was analyzed quantitatively using acid-
base equilibria of FeVI and SDZ (X) (Eqns. 4.2-4.6) (Boreen, et al., 2005; Boreen, et al., 
2005; Sharma, et al., 2006a). 
H3FeO4
+ ⇌ H+ + H2FeO4    pKa1 = 1.6    (4.2) 
H2FeO4 ⇌ H+ + HFeO4-    pKa2 = 3.5    (4.3) 
HFeO4
- ⇌ H+ + FeO42-    pKa3 = 7.23   (4.4) 
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H2X
+ ⇌ H+ + HX     pKa1  = 2.69   (4.5) 
HX ⇌ H+ + X-     pKa2  =  6.59   (4.6) 
In the pH range of 4.0 to 10.0, the four species of FeVI (i.e., H3FeO4
+, H2FeO4, HFeO4
-, 
and FeO4
2-) can possibly react with the three species of X (H2X
+, HX, and X-).  The 
dependence of k on the pH can be modeled by Eq. 4.7. 
 -d[X]/dt = k [Fe(VI)]tot [X]tot = Σ kij αi βj [Fe(VI)]tot [X]tot   (4.7) 
i = 1, 2, 3, 4, 
j = 1, 2, 3  
where [FeVI]tot = [H3FeO4
+] + [H2FeO4] + [HFeO4
-] + [FeO4
2-]; [X]tot = [H2X
+] + [HX] + 
[X-]; αi and βj represent the species fractions of Fe(VI) and SDZ, respectively; i and j are 
each of the species of Fe(VI) and SDZ respectively; and kij is the species-specific 
second-order rate constant for the reaction between the Fe(VI) species i and the X 
species j. Overall, twelve reactions could possibly contribute to Eq. (4.7). 
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Fig. 4.3. Dependence of second-order rate constants (kapp, M
-1s-1) on pH for the 
oxidation of SDZ by FeVI at 25 oC. 
96 
 
Eq. 4.7 was applied to fit the kinetic data from the oxidation of SDZ by FeVI.  
Initially, the experimental values of k at different pHs were statistically fit by involving 
sixteen reactions. In this approach, the fit obtained was very poor.  In this empirical fit, 
some values of rate constants were negative. Therefore, only reactions those gave 
positive values of the rate constants were included in the model.  This approach was 
based on earlier studies on the oxidation of sulfur-containing pharmaceuticals (e.g. 
sulfonamides) by Fe(VI) in both acid and alkaline medium (Kim, et al., 2015; Sharma, et 
al., 2006a). Only three of the possible reactions were needed to fit the results of Fig. 4.3. 
The experimental results could be described reasonably using the Eqs. 4.8-4.10. (a solid 
line in Fig. 4.3). Values of contributed species-specific rate constants are given in Eqs. 
4.8-4.10. 
H2FeO4 + SH → Fe(III) + Products  k8 = (2.7±0.5)×104 M-1s-1 (4.8) 
HFeO4
- + SH → Fe(III) + Products  k9 = (2.0±0.3)×103 M-1s-1 (4.9) 
 HFeO4
- + S-→ Fe(III) + Products  k10 = (1.6±0.5)×103 M-1s-1 (4.10) 
 The result suggests that the reactions of FeVI with the protonated species of SDZ 
(Eqs. 4.8 and 4.9) follow the order of reactivity as H2FeO4 > HFeO4
-.  This order in the 
rate constants is the same for the fractions of FeVI species at low pH and therefore 
involve in determining the overall rates of the reaction between Fe(VI) and SDZ in the 
acidic to neutral pH range, causing the increase in the rates of oxidation of SDZ by FeVI 
(Fig. 4.3).  In the neutral to basic pH range, the fraction of HFeO4
- decreases sharply 
with an increase in pH and likewise with the rate constants (see Fig. 4.3). The trend seen 
in Fig. 4.3 is consistent with the predicted variation in rates with an increase in pH using 
density functional theory calculations (Kamachi, et al., 2005). 
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4.3.2  Identification of the OPs of SDZ by Fe(VI) 
In this study, the OPs, generated via the oxidation of SD (100 μM) by Fe(VI) 
(500-2000 μM) overnight at pH 7.0, were characterized using LC-TOF-MS (ESI pos). 
Structural assignments of a total of eleven identified OPs were carried out by a product 
ion scan.  This is based on the corresponding MS/MS spectra and their proposed 
fragmentation patterns (Fig. 4.4). The data and suggested structures of the OPs and their 
MS/MS fragments are shown in Table 4.1 and Fig. 4.4 For the scientific identification of 
the possible OPs, it is necessary to analyze the mass spectrum of the parent compound 
and the fragment losses generated, which may also be detected in the structural 
identification of the OPs (Feng, et al., 2016a). Regarding SDZ (m/z 251.0578 and Rt at 
2.74 min), five main product ions at m/z 185.0807, 158.0006, 156.0102, 108.0440 and 
92.0499 corresponded to individual losses of SO2 and 2H (66 Da from SDZ), C6H5 and 
NH2 (93 Da from SDZ), C4H5N3 (95 Da from SDZ), C6H5 (77 Da from 185.0807), and 
SO2 (64 Da from 156.0102), respectively (Fig. 4.4A). Similar MS/MS fragments of SDZ 
were also reported during its catalytic peroxymonosulfate (PMS) oxidation by CuFeO2 
rhombphedral crystals (Feng, et al., 2016c). 
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Fig. 4.4. Product ion spectra of SDZ and its degradation products by Fe(VI), measured 
by LC-HR-MS/MS (ESI pos), and their proposed fragmentation pathways. 
(Experimental conditions: [SDZ]0 = 100 μM, [Fe(VI)]0 = 500-2000 μM, pH = 7.0). 
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Fig. 4.4. Continued. 
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Although the MS/MS information regarding the degradation products of SDZ by 
FeVI oxidation is still lacking, references could be found in several transformation 
studies of sulfonamides to facilitate the structural identification of these OPs (Feng, et 
al., 2016c; Kim, et al., 2015). Representatively, in this work, P267 with a protonated form 
at m/z 267.0543 and chromatographic retention time at 2.56 min was proposed as the 
product generated from the hydroxylation at the N atom between two rings of the SDZ 
molecule (Table 4.1 and Fig. 4.4B). This structure was confirmed by the product ions at 
m/z 172.0059, 158.0013, 124.0395 and 108.0450, which correspond to the separate 
losses of fragments as H2O and C6H5 (95 Da from 267.0543), H2O and C6H5N (109 Da 
from 267.0543), SO2 and C6H7 (143 Da from 267.0543), and SO2 (64 Da from 
172.0059), respectively. As another typical OP with a chromatograph retention time of 
3.42 min and two major product ions at m/z 134.0721 and 107.0618 (Table 1), P151 (m/z 
151.0983) resulted from the ring cleavage of the SDZ molecule. This structure was 
suggested mainly by the product ions at m/z 134.0721, 118.0538, 107.0618, 92.0511 and 
80.0515, which individually corresponded to the losses of such fragments as NH3 (17 Da 
from 151.0983), NH2 (16 Da from 134.0721), CHN (27 Da from 134.0721), NH (15 Da 
from 107.0618), and CHN (27 Da from 107.0618) (Fig. 4.4). Similarly, in view of the 
repeated MS/MS fragments and proposed fragmentation patterns of the OPs of SDZ, the 
individual structures of P252, P236, P188, P187, P172, P168, P152, P109 and P96 were proposed, 
and the detailed fragmentation pathways are shown in Fig. 4.4. 
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Table 4.1. Accurate mass measurements of SDZ and its transformation products by 
Fe(VI), which were determined by LC-HR-MS/MS (ESI pos). 
Compound Rt 
(min) 
Formula 
[M + H]+ 
Experimental mass 
(m/z) 
Calculated mass 
(m/z) 
Error 
(ppm) 
DBE a 
SDZ 2.74 C10H11N4O2S 251.0578 251.0603 -9.96 8 
C6H6NO2S 156.0102 156.0119 -10.90 5 
C4H4N4 108.0442 108.0436 5.55 5 
P267 2.56 C10H11N4O3S 267.0543 267.0552 -3.37 8 
C4H4N4O2S 172.0059 172.0055 2.33 5 
C4H4N4O 124.0395 124.0385 8.06 5 
P252 4.15 C10H10N3O3S 252.0417 252.0443 -10.32 8 
C10H8N3O 186.0639 186.0667 -15.05 9 
C5H5N2O2S 157.0123 157.0072 32.48 5 
P236 11.06 C10H10N3O2S 236.0441 236.0494 -22.45 8 
C10H8N3 170.0680 170.0718 -22.34 9 
C7H8N3 134.0686 134.0718 -23.87 6 
P188 7.08 C10H10N3O 188.0817 188.0824 -3.72 8 
C10H8N3 170.0712 170.0718 -3.53 9 
C4H5N4 109.0534 109.0514 18.34 5 
P187 6.64 C11H10N4 187.0979 187.0987 -4.28 9 
C10H8N3 170.0714 170.0718 -2.35 9 
C6H8N2 108.0693 108.0687 5.55 4 
P172 13.11 C10H10N3 172.0872 172.0875 -1.74 8 
C9H8N 130.0657 130.0657 0.00 7 
C6H7N 93.0588 93.0578 10.75 4 
P168 2.06 C7H10N3O2 168.0783 168.0773 5.95 5 
C7H7N2O2 151.0473 151.0508 -23.17 6 
C4H6N4 110.0574 110.0592 -16.35 4 
P152 2.50 C7H10N3O 152.0825 152.0824 0.66 5 
C7H7N2O 135.0562 135.0558 2.96 6 
C4H4N4 108.0456 108.0436 18.51 5 
P151 3.42 C7H11N4 151.0983 151.0984 -0.66 5 
C7H8N3 134.0721 134.0718 2.24 6 
C6H7N2 107.0618 107.0609 8.41 5 
P109 2.25 C6H9N2 109.0763 109.0766 -2.75 4 
C6H6N 92.0501 92.0500 1.09 5 
C5H6N 80.0507 80.0500 8.74 4 
P96 2.47 C4H6N3 96.0561 96.0562 -1.04 4 
C4H3N2 79.0305 79.0296 11.39 5 
C3H5N2 69.0464 69.0453 15.93 3 
a DBE, double bond equivalent. 
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4.3.3.  Plausible reaction pathways 
The suggested transformation pathways of SDZ by FeVI at pH 7.0 are illustrated 
in Fig. 4.5.  Three initial attack sites of SDZ by FeVI are indicated, including the SO2 
extrusion, deamination, and hydroxylation. In pathway I, SDZ could be oxidized by FeVI 
via SO2 extrusion to generate P187. Notably, SO2 extrusion has also been indicated during 
different transformation processes of sulfonamides, such as the catalytic PMS 
degradation of SDZ by CuFeO2 (Feng, et al., 2016c), the catalytic persulfate oxidation of 
sulfamonomethoxine by Fe3O4 (Yan, et al., 2011), and the triplet-sensitized 
photodegradation of sulfa drugs (Boreen, et al., 2004; Boreen, et al., 2008). 
Subsequently, the oxidation of P187 proceeded by three different patterns to form P151 
(cleavage of six-membered heterocyclic ring, which could be further transformed to be 
P109), P96 (bond cleavage) and P172 (deamination), respectively. The generation of P96 has 
recently been demonstrated during the catalytic PMS degradation of SDZ by CuFeO2 
(Feng, et al., 2016c) and its aerobic degradation by Arthrobacter spp. (Deng, et al., 
2016). Pathway II was initiated by deamination at the aromatic ring of SDZ, with the 
resultant product of P236. Because of the electron-rich moiety of an SDZ molecule, the 
amide group is susceptible to chemical attacks of FeVI via an electrophilic oxidation 
mechanism. Afterwards, pathway II continued via two sequential reaction patterns, i.e., 
SO2 extrusion and bond cleavage, to yield P172 and P96. Meanwhile, hydroxylation could 
occur for P236 to form P252. In pathway III, hydroxylation takes place on the N atom 
between two rings of SD, resulting in the formation of P267, which was also detected 
during the catalytic PMS degradation of SDZ by CuFeO2 (Feng, et al., 2016c). The 
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hydroxylation process of organic pollutants during FeVI treatment has also been 
demonstrated in recent investigations on other antibiotics such as trimethoprim 
(Anquandah, et al., 2011), sulfamethoxazole (Kim, et al., 2015), ciprofloxacin and 
enrofloxacin  (Zhou and Jiang, 2015a), as well as flumequine (Feng, et al., 2016a). With 
the reaction progressing, P252, P188, P152 and P168 were generated, mainly via 
deamination, SO2 extrusion, opening of the six-membered heterocyclic ring, and further 
hydroxylation, respectively. Overall, eleven identified OPs allowed the enhanced 
understanding of oxidation of sulfonamides by FeVI. 
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Fig. 4.5. Proposed transformation pathways of SDZ by Fe(VI). (Experimental 
conditions: [SDZ]0 = 100 μM, [Fe(VI)]0 = 500-2000 μM, pH = 7.0). 
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5. OXIDATION OF FLUMEQUINE BY FERRATE(VI), FERRATE(V), AND 
FERRATE(IV):  EFFECT OF AMMONIA ON DEGRADATION PRODUCTS 
5.1. Introduction 
Since their discovery in the 1940s, antibiotics have been widely developed and 
increasingly used as the most important pharmaceuticals for improving human health, 
treating bacterial infection, and promoting growth in animal farming (Martinez, 2009; 
Lewis, 2013). During human and veterinary applications, antibiotics are less metabolized 
due to their chemical stability.  Antibiotics are thus mainly discharged through human 
and animal excretion in which their pharmaceutically active forms remain intact in 
wastewater and soil (Homem and Santos, 2011). Notably, antibiotics even at 
environmentally relevant concentrations could trigger adverse ecological consequences, 
including the inhibition of microbial species (Ebert, et al., 2011; González-Pleiter et al., 
2013), the development of antibiotics resistant bacteria (ARB) and antibiotics resistant 
genes (ARG) with public health concerns (Ben, et al., 2017; Sharma, et al., 2016b), and 
chronic inhibitory effects on the growth and reproduction of various aquatic organisms 
(Corcoran et al., 2010; Brausch, et al., 2012). Therefore, the presence of antibiotics in 
the aquatic environment has led to the emergence of a global environmental pollution 
problem. 
Fluoroquinolone antibiotics (FQs) are the potent and broad-spectrum 
antimicrobial agents increasingly used in hospitals, households and veterinary 
applications for treating severe or resistant bacterial infections since the late 1980s 
(Chen, et al., 2015; Dorival-García, et al., 2013). Four generations of FQs have been 
105 
 
developed and examples include flumequine (FLU), norfloxacin (NOR), ofloxacin 
(OFL), lomefloxacin (LOM), and enrofloxacin (ENR) (Chen, et al., 2015; Janecko, et 
al., 2016; Khetan and Collins, 2007). After cephalosporin antibiotics, FQs have become 
the largest antibiotic drugs in the market (Hamad, 2010). FQs treat effectively both 
human and animal infections, but only a small percentage of them are retained by the 
body (Barbosa, et al., 2016; Van Doorslaer, et al., 2014). The bactericidal action of FQs 
is based on the inhibition of bacterial growth by interfering with key cellular processes 
including DNA metabolism and inhibiting the enzymes topoisomerase II (DNA-gyrase) 
in gram-negative bacteria and topoisomerase IV in gram-positive bacteria (Sukul and 
Spiteller, 2007; Janecko, et al., 2016). These processes could result in the impaired DNA 
transcription and replication (at lower concentrations) and even cell death (at lethal 
concentrations) (Sukul and Spiteller, 2007; Janecko, et al., 2016). Approximately 90% of 
the pharmaceuticals are usually released in the form of either urine or excrement (Tran, 
et al., 2016; Wang, et al., 2016). Conventional wastewater treatment technologies are not 
adequate to remove the FQs completely (Wu, et al., 2016). More and more FQs are 
entering into the environment (Chen, et al., 2015). Studies have shown their detection in 
surface water, groundwater, and soil (Chen, et al., 2015; Dekker, et al., 2015; Peixoto, et 
al., 2016). In the aquatic environment, FQs inhibit the growth of certain organisms, 
hence affecting the ecological system (Cizmas, et al., 2015). Additionally, the release of 
antibiotics leads to the development of antibiotic resistant bacteria and antibiotic 
resistant genes, an important health problem around the world (Osinska, et al., 2017; 
Proia, et al., 2016; Sharma, et al., 2016b). 
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Many treatment technologies are being investigated to remove FQs in water and 
during wastewater treatment. These removal techniques include adsorption on 
nanomaterials, reverse osmosis, smart membranes, electro-Fenton process, advanced 
oxidation processes, chlorination, ozonation, and permanganate oxidation (Dodd, et al., 
2005; Feng, et al., 2015; Feng, et al., 2016a; Feng, et al., 2016b; Guo, et al., 2017; Guo, 
et al., 2016; Jiang, et al., 2016; Jojoa-Sierra, et al., 2017; Kim, et al., 2014; Maia, et al., 
2014; Qin, et al., 2014; Santoke, et al., 2009; Sharma, et al., 2015; Wang, et al., 2010).  
Most of these methods generally give good performance in removing FQs in the 
laboratory set-up. This chapter focuses on the use of tetraoxy high-valent iron species in 
+6, +5, and +4 (FeVIO4
2- (FeVI), FeVO4
3- (FeV), and FeIVO4
4- (FeIV)), which are generally 
called ferrates, to remove a particular FQs, namely FLU. 
A recent study showed that removal of most of the studied FQs were degraded 
within 2 min at [Fe(VI)]:[FQ] ≤ 20.0, except FLU (Feng, et al., 2016a). A molar ratio of 
100:1 was needed to achieve more complete removal of FLU in water in 2 min (Feng, et 
al., 2016a). A more recent study on the removal of FLU by FeVI demonstrated the 
enhanced removal of FLU in the presence of ammonia (NH4
+ + NH3) (Feng, et al., 
2017). Some of the research in this chapter was stimulated by this surprising finding in 
which ammonia could activate FeVI to oxidize FLU so that the removal of FLU took 
place in a shorter time than without ammonia in the reaction solution (Feng, et al., 2017). 
This study postulated a formation of the intermediate highly reactive FeV-ammonia and 
FeIV-ammonia complexes during the oxidation of FLU by FeVI to cause the increased 
removal of FLU in the presence of ammonia.  This chapter aimed to test this hypothesis 
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by conducting independently the oxidation of FLU by only FeV and FeIV species.  
Initially, removal of FLU by FeVI, FeV, and FeIV species with and without ammonia was 
performed, followed by the identification of transformation products (or oxidized 
products (OPs)). Amounts of OPs were used to elucidate the role of intermediate iron 
species in the oxidation of FLU by FeVI in the presence of ammonia. 
5.2. Materials and methods 
5.2.1. Chemicals 
FLU (purity 98%) was obtained from Sigma-Aldrich (St. Louis, Mossouri, 
USA).  Salts of ammonium ion (NH4Cl) and buffers (sodium dihydrogen phosphate 
(Na2HPO4) and sodium tetraborate decahydrate (Na2B4O7
.10H2O)) were purchased from 
Sigma-Aldrich (St. Louis, Mossouri, USA).  Methanol and formic acid of HPLC grade 
were acquired from Merck (Darmstadt, Germany). A wet chemical method was applied 
to synthesize solid potassium ferrate (K2FeO4, purity > 95%) (Luo, et al., 2011).  Solid 
salts of FeIV (Na4FeO4) and Fe
V (K3FeO4) were prepared using thermal techniques 
(Kralchevska, et al., 2016; Machalová Šišková, et al., 2016). The purities of these salts 
were evaluated by 57Fe Mössbauer spectroscopy (Sharma, et al., 2015). The purity of 
Na4FeO4 was high (> 90%) (Sharma, et al., 2015). In the salt of K3FeO4, 75% was Fe
V 
and 25% was FeVI.  The water used in preparing solutions throughout the experiments 
was ultrapure (> 18.2 MΩ cm), which was produced from a Milli Q Plus system 
(Millipore, Bedford, USA). Solutions of FLU with and without ammonia (NH4
+) were 
prepared in a 0.01 M phosphate buffer solution. The pH of the buffer solution was 
adjusted using phosphoric acid.  An Orion 710A pH meter system equipped with an 
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Accumet pH probe (± 0.05 pH at 25 °C) was used for all pH measurements.  
5.2.2. Removal of FLU by FeVI, FeV, and FeIV and the influence of ammonia 
The removal experiments at pH 7.0 were performed in a Coy glove box with a 
vinyl anaerobic chamber under dry N2 atmosphere in order to prevent the decay of 
ferrates to iron(III) by ambient air humidity. A batch of 20 mL solutions containing 30 
µM FLU with and without 10 mM ammonia was prepared, and the pH was adjusted at 
pH 7.0 using phosphoric acid. After the preparation of the 30 µM FLU solution, solid 
compounds of FeVI, FeV, and FeIV were directly added to the FLU solution.  The final 
concentrations of FeVI, FeV, and FeIV in the mixed solutions were 300 µM, 600 µM, 
1500 µM, and 3000 µM. In the case of the reaction of FLU with FeVI, the disappearance 
of the characteristic color of FeVI in the mixture indicated that the reaction was complete. 
This was also confirmed by performing absorbance measurement that showed the 
disappearance of an absorbance peak at 510 nm for FeVI. In studying the reactions of 
FLU with FeVI and FeIV, after adding solid salts to the 30 µM FLU solution,  reactions 
were immediately stopped (within 10 s) by adding excessive hydroxylamine as an 
quenching reagent. The concentration of hydroxylamine in the reaction mixture was 30 
mM.  Hydroxylamine reacted rapidly with FeVI, hence no significant reaction of FeVI 
with FLU could occur (Johnson and Hornstein, 2003). As written in section 2.1, a salt of 
FeV had an impurity of FeVI, which could possibly interfere with the reaction of FeV with 
FLU.  Furthermore, both FeV and FeIV species also simultaneously decay themselves in 
water (Menton and Bielski, 1990; Rush and Bielski, 1989; Rush and Bielski, 1994) to 
give FeVI ion (Yates, et al., 2014). A rapid addition of hydroxylamine to the mixed 
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solutions of FeV-FLU and FeIV-FLU avoided any interference from the oxidation of FLU 
by FeVI.  This experimental approach studied only the products from the reaction of FeV 
and FLU and FeIV-FLU. 
5.2.3. Analytical procedures 
Concentrations of FLU were determined by an Agilent 1200 high performance 
liquid chromatograph (HPLC) (Agilent Technologies, Palo Alto, CA, USA), which was 
equipped with a quaternary pump and a diode array detector at 248 nm. 
Chromatographic analysis was performed at a flow rate of 1.0 mL/min on a Zorbax 
Eclipse XDB-C18 analytical column (4.6 mm × 150 mm, particle size 5 μm) (Agilent 
Technologies, Palo Alto, CA, USA) at 30 °C. The mobile phase applied to obtain the 
chromatographic peak was 0.3% formic acid in water (A) and methanol (B) with an 
isocratic elution of 50/50 (v/v). The elution time of the peak was 5.5 min.  The injected 
volume was 20 μL. 
The transformation products in the oxidation of FLU by FeVI and FeV in the 
presence or absence of ammonia were identified by solid phase extraction-liquid 
chromatography-high-resolution mass spectrometry (SPE-LC-HRMS) (Feng, et al., 
2016a). The protonated molecular ions [M + H]+ of certain products were chosen as the 
parent ions to obtain the characteristic MS/MS fragments, which facilitated their 
structural identification. An error of < 3 ppm between the observed mass measurements 
and the proposed molecular formulas was utilized to identify accurate evaluations of the 
fragments and their elemental compositions. 
5.3.  Results and discussion 
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5.3.1. Removal 
 In this set of experiments, different amounts of FeVI, FeV, and FeIV were added 
into 30 μM FLU at pH 7.0. The varied molar ratios of oxidants to FLU were in the range 
from 10:1 to 100:1. Results of the remaining FLU with and without ammonia at different 
molar ratios are presented in Fig. 5.1. FeVI fully removed FLU at a molar ratio of 100:1 
([FeVI]:[FLU]) in the absence of ammonia. However, ammonia’s presence in the reaction 
solution decreased the required molar ratio to 50:1 for completely removing FLU (Fig. 
5.1). Comparatively, FeV could remove only 8% at the highest molar ratio of 100:1. 
Importantly, the presence of ammonia achieved the same removal of FLU of 8% at a 
molar ratio of 50:1. Furthermore, when a molar ratio was increased to 100:1 in the 
presence of ammonia, removal of FLU increased to 20% by FeV. In the case of FeIV, no 
removal of FLU was observed with or without ammonia in the reaction solution. Similar 
efficiencies of ferrate species were seen in removing estrogens in water (Machalová 
Šišková, et al., 2016). 
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Fig. 5.1.  Oxidation of FLU by FeVI, FeV, and FeIV species with and without ammonia at 
pH 7.0.  ([FLU] = 30 µM).  
 
5.3.2.  Identification of oxidized products 
In this study, OPs of the reactions between FeVI/FeV with FLU at pH 7.0 in the 
absence and presence of ammonia were determined. When FeVI was applied as an 
oxidant, OPs were identified at the molar ratios of 50:1 and 100:1 ([FeVI]:[FLU]) with 
and without ammonia. At these molar ratios, high percentages of FLU removal (80-100 
%) with and without ammonia were obtained (Fig. 5.1). OPs were identified by LC-
HRMS (ESI pos) (Table 5.1). As shown in Figs. 5.2-5.19, seventeen OPs were 
characterized, and their formulas and structures were assigned using extracted ion 
chromatograms (XIC) and MS/MS spectra. The identified OPs were named, based on 
the proposed reaction schemes, as Scheme I: P312, P296, P278’, P234, P220, P312, P268, P224, 
Scheme II: P294, P250, P236, P222, P208, P266, P238, and P210 and Scheme III:  P278’’ and P276 
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(Fig. 5.20). Similar OPs were seen during the oxidation of FLU by FeVI without 
ammonia (Feng, et al., 2016a). 
Scheme I represents the hydroxylation at the C12=C13 double bond due to its 
high electron-cloud density (i.e., hydroxylation of the quinolone ring). P234 and P296 were 
obtained from the ring cleavage of the product, P278’. The formation of P234 occurred 
from the decarboxylation of P278’. The demethylation of P234 yielded P220. When P296 
cleaved, it generated P224, P312, and P268 (Scheme I).  In the Scheme II, a ring opening 
happened in which FeVI attacked the double bond of the quinolone ring via a 1,3-dipolar 
cycloaddition to produce P294. P250 and P266 were produced from the further reactions of 
P294. Steps of decarboxylation, decarbonylation, hydroxylation, and demethylation of 
P250 and P266 produced P236, P208, P222, P238 and P210 (Scheme II). The simple addition of 
a hydroxyl group at the C10 position of FLU gave P278’’, which on further oxidation 
resulted in P276. 
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Table 5.1. Accurate mass measurements of FLU and its transformation products by 
Fe(VI), which were determined by LC-HR-MS/MS (ESI pos). 
Compound Rt 
(min) 
Formula 
[M + H]+ 
Experimental mass 
(m/z) 
Calculated mass 
(m/z) 
Error 
(ppm) 
DBE a 
FLU 13.51 C14H13FNO3 262.0873 262.0879 -2.29 9 
C14H11FNO2 244.0769 244.0774 -2.05 10 
C11H5FNO2 202.0299 202.0304 -2.47 10 
P312 11.90 C14H15FNO6 312.0865 312.0883 -5.77 8 
C14H13FNO5 294.0764 294.0778 -4.76 9 
C14H11FNO4 276.0659 276.0672 -4.71 10 
P296 11.15 C14H15FNO5 296.0927 296.0934 -2.36 8 
C14H13FNO4 278.0823 278.0829 -2.16 9 
C14H11FNO3 260.0717 260.0723 -2.31 10 
P294 12.48 C14H13FNO5 294.0769 294.0778 -3.06 9 
C14H11FNO4 276.0663 276.0672 -3.26 10 
C14H9FNO3 258.0556 258.0566 -3.88 11 
P278’, P278’’ 12.16, 
12.44 
C14H13FNO4 278.0823 278.0829 -2.16 9 
C14H11FNO3 260.0714 260.0723 -3.46 10 
C14H9FNO2 242.0612 242.0617 -2.07 11 
P276 10.75 C14H11FNO4 276.0662 276.0672 -3.62 10 
C14H9FNO3 258.0557 258.0566 -3.49 11 
C14H11FNO2 244.0762 244.0774 -4.92 10 
P268 11.94 C13H15FNO4 268.0950 268.0985 -13.05 7 
C13H13FNO3 250.0879 250.0879 0.00 8 
C12H13FNO2 222.0915 222.0930 -6.75 7 
P266 10.79 C13H13FNO4 266.0825 266.0829 -1.50 8 
C12H13FNO3 238.0871 238.0879 -3.36 7 
C12H11FNO2 220.0766 220.0774 -3.64 8 
P250 11.88 C13H13FNO3 250.0872 250.0879 -2.80 8 
C12H13FNO2 222.0921 222.0930 -4.05 7 
C10H7FNO3 208.0401 208.0410 -4.33 8 
P238 10.62 C12H13FNO3 238.0875 238.0879 -1.68 7 
C12H11FNO2 220.0772 220.0774 -0.91 8 
C11H13FNO2 210.0930 210.0930 0.00 6 
P236 12.82 C12H11FNO3 236.0716 236.0723 -2.97 8 
C12H9FNO2 218.0609 218.0617 -3.67 9 
C11H7FNO2 204.0456 204.0461 -2.45 9 
P234 14.27 C13H13FNO2 234.0924 234.0930 -2.56 8 
C11H7FNO2 204.0457 204.0461 -1.96 9 
C10H7FNO2 192.0455 192.0461 -3.12 8 
P224 17.23 C12H15FNO2 224.1079 224.1087 -3.57 6 
C11H11FNO 192.0819 192.0825 -3.12 7 
C10H11FN 164.0869 164.0876 -4.27 6 
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Table 5.1. Continued. 
Compound Rt 
(min) 
Formula 
[M + H]+ 
Experimental mass 
(m/z) 
Calculated mass 
(m/z) 
Error 
(ppm) 
DBE a 
P222 12.84 C12H13FNO2 222.0925 222.0930 -2.25 7 
C12H11FNO 204.0814 204.0825 -5.39 8 
C11H13FNO 194.0972 194.0981 -4.64 6 
P220 10.75 C12H11FNO2 220.0769 220.0774 -2.27 8 
C10H7FNO2 192.0459 192.0461 -1.04 8 
C9H5FNO2 178.0302 178.0304 -1.12 8 
P210 12.36 C11H13FNO2 210.0926 210.0930 -1.90 6 
C11H11FNO 192.0818 192.0825 -3.64 7 
C10H11FN 164.0869 164.0876 -4.27 6 
P208 14.05 C11H11FNO2 208.0764 208.0774 -4.81 7 
C11H9FNO 190.0657 190.0668 -5.79 8 
C10H9FNO 178.0655 178.0668 -7.30 7 
a DBE: double bond equivalent. 
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Fig. 5.2. Extracted ion chromatogram (XIC), MS/MS spectra, and proposed MS/MS fragmentation patterns of FLU (m/z 
262.0873). 
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Fig. 5.3. Extracted ion chromatogram (XIC), MS/MS spectra, and proposed MS/MS fragmentation patterns of P312 (m/z 
312.0865). 
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Fig. 5.4. Extracted ion chromatogram (XIC), MS/MS spectra, and proposed MS/MS fragmentation patterns of P296 (m/z 
296.0927). 
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Fig. 5.5. Extracted ion chromatogram (XIC), MS/MS spectra, and proposed MS/MS fragmentation patterns of P294 (m/z 
294.0769). 
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Fig. 5.6. Extracted ion chromatogram (XIC), MS/MS spectra, and proposed MS/MS fragmentation patterns of P278
’ (m/z 
278.0823). 
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Fig. 5.7. Extracted ion chromatogram (XIC), MS/MS spectra, and proposed MS/MS fragmentation patterns of P278’’ (m/z 
278.0823). 
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Fig. 5.8. Extracted ion chromatogram (XIC), MS/MS spectra, and proposed MS/MS fragmentation patterns of P276 (m/z 
276.0662). 
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Fig. 5.9. Extracted ion chromatogram (XIC), MS/MS spectra, and proposed MS/MS fragmentation patterns of P268 (m/z 
268.0950). 
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Fig. 5.10. Extracted ion chromatogram (XIC), MS/MS spectra, and proposed MS/MS fragmentation patterns of P266 (m/z 
266.0825). 
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Fig. 5.11. Extracted ion chromatogram (XIC), MS/MS spectra, and proposed MS/MS fragmentation patterns of P250 (m/z 
250.0872). 
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Fig. 5.12. Extracted ion chromatogram (XIC), MS/MS spectra, and proposed MS/MS fragmentation patterns of P238 (m/z 
238.0875). 
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Fig. 5.13. Extracted ion chromatogram (XIC), MS/MS spectra, and proposed MS/MS fragmentation patterns of P236 (m/z 
236.0716). 
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Fig. 5.14. Extracted ion chromatogram (XIC), MS/MS spectra, and proposed MS/MS fragmentation patterns of P234 (m/z 
234.0924). 
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Fig. 5.15. Extracted ion chromatogram (XIC), MS/MS spectra, and proposed MS/MS fragmentation patterns of P224 (m/z 
224.1079). 
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Fig. 5.16. Extracted ion chromatogram (XIC), MS/MS spectra, and proposed MS/MS fragmentation patterns of P222 (m/z 
222.0925). 
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Fig. 5.17. Extracted ion chromatogram (XIC), MS/MS spectra, and proposed MS/MS fragmentation patterns of P220 (m/z 
220.0769). 
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Fig. 5.18. Extracted ion chromatogram (XIC), MS/MS spectra, and proposed MS/MS fragmentation patterns of P210 (m/z 
210.0926). 
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Fig. 5.19. Extracted ion chromatogram (XIC), MS/MS spectra, and proposed MS/MS fragmentation patterns of P208 (m/z 
208.0764).
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Fig. 5.20.  Proposed reaction schemes of the oxidation of FLU by FeVI and FeV in the presence of 10 mM ammonia at pH 7.0 
and 25 °C. 
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Scheme II 
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Scheme III 
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Fig. 5.20. Continued. 
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The influence of ammonia on enhanced removal of FLU by FeVI and FeV was 
understood by comparing the peak areas of the obtained OPs at molar ratios of 50:1 and 
100:1 with and without ammonia (Figs. 5.21 and 5.22). As shown in Scheme I of Fig. 
5.21, the presence of ammonia resulted in higher peak areas of products P234, P312, and 
P268.  These products suggest that ammonia in a reaction solution of Fe
VI-FLU could 
increase the attack on the double bond of C12=C13. This phenomenon of FeVI due to the 
presence of ammonia was also observed in the Scheme II of Fig. 20, which had higher 
peak areas of the products P294 and P250 in the presence of ammonia than in the absence 
of ammonia. Again, both of these products were obtained by the enhanced attack of 
oxidant(s) in the presence of ammonia on the double bond of the quinolone ring of FLU. 
These oxidants could be either FeVI-ammonia or FeV-ammonia or both species. The 
reasons for such possibility are based on available literatures on the high reactivity of 
high-valent iron compounds containing nitrogen-containing ligands (Ansari, et al., 2013; 
Berry, et al., 2006; McDonald and Que, 2013; Mills, et al., 2016; Scepaniak, et al., 
2011). The peak areas of Fig. 5.21 suggest that FeVI-ammonia and FeV-ammonia 
complexes reacted faster at the double bond moiety of FLU than the un-complexed FeVI 
and FeV species. Furthermore, the peak areas of the products of Scheme III of Fig. 5.20 
in the presence of ammonia were lower than those in the absence of ammonia. This 
further suggests the preference of FeVI-ammonia and FeV-ammonia complexes to 
produce OPs by involving the C12=C13 double bond of FLU. 
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Fig. 5. 21. Peak areas of oxidized products in different schemes in reactions of FeVI with FLU with and without ammonia. 
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Fig. 5.22. Peak areas of oxidized products in different schemes in reactions of FeV with FLU with and without ammonia.
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The involvement of FeV species in the oxidation of FLU by FeVI was observed in 
results of experiments carried out by using only FeV in the absence and presence of 
ammonia (Fig. 5.21). Black and red bars represent the same percentages of removal of 
FLU by FeV in the absence and presence of ammonia, respectively.  However, peaks 
areas of OPs of the reaction schemes of Fig. 5.20 were greater with ammonia than 
without ammonia in the reaction solution of FeV-FLU.  Significantly, the observation of 
similar OPs using only FeV supports the participation of FeV species in the degradation 
of FLU by FeV. Furthermore, enhanced peak areas due to the presence of ammonia again 
provide evidence that the FeV-ammonia complex may also be causing the enhanced 
oxidation at the C12=C13 double bond of FLU (see peak areas of Schemes I and II of 
Fig. 5.21). Similarly, such FeV-ammonia complexes could also increase hydroxylation at 
the C10 site of the FLU (see peak areas of Scheme III of Fig. 5.21). It appears from the 
results of peak areas of OPs in the absence and presence of ammonia that the nature of 
the reactive high-valent iron oxidant species in FeVI/FeV-ammonia-FLU mixtures were 
different from that present in FeVI/FeV-FLU solutions.  
139 
 
6.  CONCLUSIONS 
6.1. Summary 
In this dissertation, aqueous transformations of three emerging micro-pollutants, 
including MC-LR (a representative cyclic heptapeptide toxin produced by cyanobacterial 
species), SDZ and FLU (two typical antibiotics of sulfonamides and fluoroquinolones), 
by high-valent iron species (FeVI, FeV, and FeIV) were carried out. Specifically, the 
additions and concentration effects of these three ferrates as well as those of the solution 
pH values on the transformation products and mechanisms of MC-LR were investigated. 
Regarding SDZ, the kinetics of the reaction between FeVI and SDZ as a function of pH 
were studied to determine the species-specific rate constants, while the products and 
pathways of SDZ by FeVI were first measured and proposed. Additionally, the effects of 
ammonia on the oxidation of FLU by three ferrate species in the reaction solution were 
also investigated. The main conclusions of these studies are as follows: 
(i) Based on seventeen identified products of MC-LR by FeVI, FeV and FeIV species 
at varying concentrations of 200 µM, 400 µM and 850 µM at pH 7.0, three reaction 
mechanisms were proposed, including hydroxylation at the Adda diene, elimination of 
the methoxy group of the Adda diene, and hydroxylation at the diene bond of the Mdha. 
Notably, the results demonstrated the hydroxylation of the aromatic ring of MC-LR by 
all these ferrate species, while hydroxylation and breakage of the peptide ring were also 
involved. The increasing concentrations of these oxidants for MC-LR oxidation showed 
that the product distribution may be not only related to differences in the nature of high-
valent iron species, but also to their tendency in water to perform oxidation reactions. 
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FeVI is much more stable than FeV and FeIV species in water; therefore, FeVI would have 
a prolonged presence to yield  OPs with lower molecular weight. 
In addition, the influence of the solution pH (4.0, 7.0, and 9.0) on the oxidation of 
MC-LR by FeVI, FeV and FeIV was also investigated. The results indicated that the 
hydroxylation of the Adda diene and at the diene bond of the Mdha of MC-LR by all 
these ferrate species was greatly favored by acidic conditions compared to neutral and 
basic pH environments. In the initial step by MC-LR, the elimination of the methoxy 
moiety was seen only in the oxidation by FeV and FeIV, which was independent of the 
solution pH. Furthermore, the final products of the elimination of the methoxy processes 
were also independent of the pH. 
(ii) The oxidation kinetic investigation of SDZ by FeVI indicated that the reaction 
followed the second-order kinetics, i.e., first-order with respect to each reactant. The 
measured values of the second-order rate constants decreased along with the increasing 
pH from 4.0 to 10.0, which can be successfully modeled by using equilibrium species of 
FeVI and SDZ, i.e., the protonation of FeVI increased the reactivity with the neutral 
species of SDZ. Based on eleven identified OPs of SDZ by LC-TOF-MS (ESI pos) in a 
product ion scan, the transformation pathways of SDZ by FeVI oxidation included three 
initial attacks, including SO2 extrusion, deamination, and hydroxylation. Notably, the 
presence of FeVI resulted in SO2 extrusion for the first time during the transformation of 
SDZ. Meanwhile, some other reactions such as opening of the six-membered 
heterocyclic ring were also involved. 
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(iii) The removal studies indicated that, at the test concentrations of three ferrate 
species, only FeVI could remove FLU completely at pH 7.0, followed by FeV (~20% 
removal of FLU) and FeIV (no removal of FLU). It appears that the self-decomposition 
rates of FeV and FeIV species in water were faster than their reactions with FLU at pH 
7.0, since they possess a higher reactivity to pollutants than FeVI. In the presence of 
ammonia, the removal of FLU by FeVI and FeV species was enhanced, and this may be 
attributed to the formation of higher reactive FeVI-ammonia and FeV-ammonia 
complexes rather than to un-complexed FeVI and FeV species. The peak areas of the 
identified products and the proposed mechanisms indicated that the former complexes 
reacted faster at the double bond moiety of the quinolone ring of FLU than the latter 
species, leading to the larger amounts of certain OPs in the presence of ammonia than in 
the absence of ammonia. 
6.2. Outlook 
The current studies presented some detailed investigations regarding the 
transformation processes and mechanisms of three typical micro-pollutants (MC-LR, 
SDZ and FLU) by three ferrate species (FeVI, FeV, and FeIV) in water. Based on these 
findings, future researches may be performed aimed at the following aspects: 
(i) As can be learned from MC-LR, other microcystins such as microcystin-LA, 
microcystin-RR, and microcystin-YR can be further investigated and compared to learn 
if amino acids have any influence on kinetics and products after treatments by three 
high-valent iron species, i.e., FeVI, FeV, and FeIV. In addition, the possible influences of 
more environmental factors, such as solution pH, co-existing cations and anions, natural 
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organic matters and even different water matrices, could be studied to learn the 
efficiency and practicality of ferrate technologies for removing these kinds of toxins 
from the real water environment. 
(ii) Regarding SDZ, it is noteworthy that SO2 extrusion occurred during its 
oxidation by FeVI in water. In future degradation studies, we could explore any other 
sulfonamides to determine if SO2 extrusion is also happening in those molecules during 
aqueous transformation by three different ferrate species, and therefore, more detailed 
mechanisms for this reaction should be investigated. In addition, the formation of the 
resultant products should be further structurally demonstrated by comparing them with 
the corresponding standard chemicals or by using more systematical analytical 
approaches such as FT-IR and NMR. Meanwhile, some quantum chemical methods, 
including the frontier molecular orbitals, transition states, and reaction energy barriers, 
may be applied to provide theoretical guidelines and confirmations for the reaction 
mechanisms. 
(iii) Notably, it is observed that the removal percentage of FLU could be improved 
by the use of ammonia-activated FeVI and FeV. In subsequent studies, similar enhanced 
effects of ammonia should be investigated for other FQs to learn if ferrate technologies 
could be used as the preferential and alternative treatments for the remediation of 
ammonia-containing wastewaters polluted by FQ residues. 
(iv) Overall, the removal experiments of micro-pollutants by ferrates in the present 
thesis were performed using lab-scale methods.  In future, efforts should be made to 
facilitate their practical applications in water and wastewater treatment. Generally, the 
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superior oxidation/disinfection and coagulation properties of ferrates over conventional 
treatment chemicals can meet the new challenges confronting the water industry in 
treating effectively both organic and inorganic contaminants.  Additionally, concerns 
related to toxic by-products (e.g., chlorinated by-products from chlorination, 
nitrosoamines from chloramination, and bromate formation from the ozonation of 
bromide-containing water) can be addressed successfully using ferrate technology.  Any 
practical application of ferrate in real water treatment settings (i.e., plant scale facilities) 
would require detailed investigation of the stability of ferrates species in the wastewater 
matrices.  A cost effectiveness of the use of ferrates also needs to be evaluated in order 
to apply ferrates as an environmental friendly technology to remediate pollutants in 
water and wastewater. 
  
144 
 
REFERENCES 
Acero, J.L., RodriÌguez, E., Majado, M.E., Sordo, A., Meriluoto, J., 2008. Oxidation of 
microcystin-LR with chlorine and permanganate during drinking water treatment. J. 
Water Supply: Res. Technol. - AQUA. 57, 371-380.  
Adamovsky, O., Moosova, Z., Pekarova, M., Basu, A., Babica, P., Svihalkova 
Sindlerova, L., Kubala, L., Blaha, L., 2015. Immunomodulatory potency of microcystin, 
an important water-polluting cyanobacterial toxin. Environ. Sci. Technol. 49, 12457-
12464.  
Anquandah, G.A.K., Sharma, V.K., Knight, D.A., Batchu, S.R., Gardinali, P.R., 2011. 
Oxidation of trimethoprim by ferrate(VI): kinetics, products, and antibacterial activity. 
Environ. Sci. Technol. 45, 10575-10581.  
Ansari, A., Kaushik, A., Rajaraman, G., 2013. Mechanistic insights on the ortho-
hydroxylation of aromatic compounds by non-heme iron complex: A computational case 
study on the comparative oxidative ability of ferric-hydroperoxo and high-valent FeIV=O 
and FeV=O intermediates. J. Am. Chem. Soc. 135, 4235-4249.  
Antoniou, M.G., de la Cruz, A.A., Dionysiou, D.D., 2010. Intermediates and reaction 
pathways from the degradation of microcystin-LR with sulfate radicals. Environ. Sci. 
Technol. 44, 7238-7244.  
Antoniou, M.G., Shoemaker, J.A., de la Cruz, A.A., Dionysiou, D.D., 2008. Unveiling 
new degradation intermediates/pathways from the photocatalytic degradation of 
microcystin-LR. Environ. Sci. Technol. 42, 8877-8883.  
145 
 
aus der Beek, T., Weber, F.A., Bergmann, A., Hickmann, S., Ebert, I., Hein, A., Küster, 
A., 2016. Pharmaceuticals in the environment-global occurrences and perspectives. 
Environ. Toxicol. Chem. 35, 823-835.  
Backer, L.C., Manassaram-Baptiste, D., LePrell, R., Bolton, B., 2015. Cyanobacteria 
and algae blooms: Review of health and environmental data from the harmful algal 
bloom-related illness surveillance system (HABISS) 2007–2011. Toxins 7, 1048-1064.  
Barbosa, M.O., Moreira, N.F.F., Ribeiro, A.R., Pereira, M.F.R., Silva, A.M.T., 2016. 
Occurrence and removal of organic micropollutants: An overview of the watch list of 
EU Decision 2015/495. Water Res. 94, 257-279.  
Ben, W., Wang, J., Cao, R., Yang, M., Zhang, Y., Qiang, Z., 2017. Distribution of 
antibiotic resistance in the effluents of ten municipal wastewater treatment plants in 
China and the effect of treatment processes. Chemosphere 172, 392-398.  
Bernasconi, L., Louwerse, M.J., Baerends, E.J., 2007. The role of equatorial and axial 
ligands in promoting the activity of non-heme oxidoiron(IV) catalysts in alkane 
hydroxylation. Eur. J. Inorg. Chem. 19, 3023-3033.  
Berry, J.F., Bill, E., Bothe, E., George, S., Mienert, B., Neese, F., Wieghardt, K., 2006. 
An octahedral coordination complex of iron(VI). Science 312, 1937-1941.  
Bielski, B.H.J., Sharma, V.K., Czapski, G., 1994. Reactivity of ferrate(V) with 
carboxylic acids: a pre-mix pulse radiolysis study. Radiat. Phys. Chem. 44, 479-484.  
Boreen, A.L., Arnold, W.A., McNeill, K., 2004. Photochemical fate of sulfa drugs in 
then aquatic environment: sulfa drugs containing five-membered heterocyclic groups. 
Environ. Sci. Technol. 38, 3933-3940.  
146 
 
Boreen, A.L., Arnold, W.A., McNeill, K., 2005. Triplet-sensitized photodegradation of 
sulfa drugs containing six-membered heterocyclic groups: Identification of an SO2 
extrusion photoproduct. Environ. Sci. Technol. 39, 3630-3638.  
Boreen, A.L., Edhlund, B.L., Cotner, J.B., McNeill, K., 2008. Indirect photodegradation 
of dissolved free amino acids: The contribution of singlet oxygen and the differential 
reactivity of DOM from various sources. Environ. Sci. Technol. 42, 5492-5498.  
Botana, L.M., 2016. Toxicological perspective on climate change: aquatic toxins. Chem. 
Res. Toxicol. 29, 619-625.  
Boxall, A.B.A., Rudd, M.A., Brooks, B.W., Caldwell, D.J., Choi, K., Hickmann, S., 
Innes, E., Ostapyk, K., Staveley, J.P., Verslycke, T., 2012. Pharmaceuticals and personal 
care products in the environment: what are the big questions? Environ Health Perspect. 
120, 1221-1229.  
Brausch, J.M., Connors, K.A., Brooks, B.W., Rand, G.M., 2012. Human 
pharmaceuticals in the aquatic environment: A review of recent toxicological studies and 
considerations for toxicity testing. Rev. Environ. Contam. T. 218, 1-99. 
Bu, Q.W., Wang, B., Huang, J., Deng, S.B., Yu, G., 2013. Pharmaceuticals and personal 
care products in the aquatic environment in China: A review. J. Hazard. Mater. 262, 189-
211. 
Buratti, F.M., Scardala, S., Funari, E., Testai, E., 2011. Human glutathione transferases 
catalyzing the conjugation of the hepatoxin microcystin-LR. Chem. Res. Toxicol. 24, 
926-933.  
147 
 
Campinas, M., Rosa, M.J., 2010. Removal of microcystins by PAC/UF. Sep. Purif. 
Technol. 71, 114-120.  
Carr, J.D., 2008. Kinetics and product identification of oxidation by ferrate(VI) of water 
and aqueous nitrogen containing solutes. ACS Symp. Ser. 985(Ferrates), 189-196.  
Carraro, E., Bonetta, S., Bertino, C., Lorenzi, E., Bonetta, S., Gilli, G., 2016. Hospital 
effluents management: chemical, physical, microbiological risks and legislation in 
different countries. J. Environ. Manage. 168, 185-199.  
Carvalho, I.T., Santos, L., 2016. Antibiotics in the aquatic environments: A review of the 
European scenario. Environ. Int. 94, 736-757.  
Cataldo, F., Ragni, P., Iglesias-Groth, S., Manchado, A., 2011. Solid state radiolysis of 
sulphur-containing amino acids: Cysteine, cystine and methionine. J. Radioanal. Nucl. 
Chem. 287, 573-580.  
Cavazza, C., Bochot, C., Rousselot-Pailley, P., Carpentier, P., Cherrier, M.V., Martin, 
L., Marchi-Delapierre, C., Fontecilla-Camps, J.C., Ménage, S., 2010. Crystallographic 
snapshots of the reaction of aromatic C-H with O2 catalysed by a protein-bound iron 
complex. Nature Chem. 2, 1069-1076.  
Chanda, A., Khetan, S.K., Banerjee, D., Ghosh, A., Collins, T.J., 2006. Total 
degradation of fenitrothion and other organophosphorus pesticides by catalytic oxidation 
employing Fe-TAML peroxide activators. J. Am. Chem. Soc. 128, 12058-12059.  
Chen, G., Li, M., Liu, X., 2015. Fluoroquinolone antibacterial agent contaminants in 
soil/groundwater: A literature review of sources, fate, and occurrence. Water Air Soil 
Pollut. 226, 1-11.  
148 
 
Chen, L., Chen, J., Zhang, X., Xie, P., 2016. A review of reproductive toxicity of 
microcystins. J. Hazard. Mater. 301, 381-399.  
Chen, L., Mendoza, I., Gardinali, P.R., O’Shea, K.E., Dionysiou, D.D., Zboril, R., 
Sharma, V.K., 2017. Oxidation of microcystin-LR by FeVI, FeV, and FeIV: Degradation 
pathways. Chem. Eng. J., Submitted.  
Chierentin, L., Salgado, H.R.N., 2016. Review of properties and analytical methods for 
the determination of norfloxacin. Crit. Rev. Anal. Chem. 46, 22-39.  
Cho, K.B., Hirao, H., Shaik, S., Nam, W., 2016. To rebound or dissociate? This is the 
mechanistic question in C-H hydroxylation by heme and nonheme metal-oxo complexes. 
Chem. Soc. Rev. 45, 1197-1210.  
Cizmas, L., Sharma, V.K., Gray, C., McDonald, T.J., 2015. Pharmaceuticals and 
personal care products in waters: occurrence, toxicity, and risk. Environ. Chem. Lett. 13, 
381-394.  
Corcoran, J., Winter, M.J., Tyler, C.R., 2010. Pharmaceuticals in the aquatic 
environment: A critical review of the evidence for health effects in fish. Crit. Rev. 
Toxicol. 40, 287-304. 
Craig, M., Luu, H.A., McCready, T.L., Williams, D., Andersen, R.J., Holmes, C.F.B., 
1996. Molecular mechanisms underlying the interaction of motuporin and microcystins 
with type-1 and type-2A protein phosphatases. Biochem. Cell Biol. 74, 569-578.  
Dawson, J.F., Holmes, C.F., 1999. Molecular mechanisms underlying inhibition of 
protein phosphatases by marine toxins. Front. Biosci. 4. D646-D658. 
149 
 
De Freitas, A.M., Sirtori, C., Lenz, C.A., Zamora, P.G.P., 2013. Microcystin-LR 
degradation by solar photo-Fenton, UV-A/photo-Fenton and UV-C/H2O2: A comparative 
study. Photochem. Photobiol. Sci. 12, 696-702.  
de la Cruz, A.A., Antoniou, M.G., Hiskia, A., Pelaez, M., Song, W., O'Shea, K.E., He, 
X., Dionysiou, D.D., 2011. Can we effectively degrade microcystins? - Implications on 
human health. Anti-Cancer Agent. ME. 11, 19-37.  
Dekker, D.M., Krumkamp, R., Sarpong, N., Frickmann, H., Boahen, K.G., Frimpong, 
M., Asare, R., Larbi, R., Hagen, R.M., Poppert, S., Rabsch, W., Marks, F., Sarkodie, 
Y.A., May, J., 2015. Drinking water from dug wells in rural Ghana — Salmonella 
contamination, environmental factors, and genotypes. Int. J. Environ. Res. Public Health. 
12, 3535-3546.  
Deng, Y., Mao, Y., Li, B., Yang, C., Zhang, T., 2016. Aerobic degradation of 
sulfadiazine by arthrobacter spp.: Kinetics, pathways, and genomic characterization. 
Environ. Sci. Technol. 50, 9566-9575.  
Dodd, M.C., Shah, A.D., Von Gunten, U., Huang, C.H., 2005. Interactions of 
fluoroquinolone antibacterial agents with aqueous chlorine: Reaction kinetics, 
mechanisms, and transformation pathways. Environ. Sci. Technol. 39, 7065-7076.  
Dorival-García, N., Zafra-Gómez, A., Cantarero, S., Navalón, A., Vílchez, J.L., 2013. 
Simultaneous determination of 13 quinolone antibiotic derivatives in wastewater 
samples using solid-phase extraction and ultra performance liquid chromatography-
tandem mass spectrometry. Microchem. J. 106, 323-333.  
150 
 
Drobac, D., Tokodi, N., Lujic, J., Marinovic, Z., Subakov-Simic, G., Dulic, T., Važic, 
T., Nybom, S., Meriluoto, J., Codd, G.A., Svircev, Z., 2016. Cyanobacteria and 
cyanotoxins in fishponds and their effects on fish tissue. Harmful Algae 55, 66-76.  
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